<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7762000</article-id><article-id pub-id-type="pmid">33291844</article-id><article-id pub-id-type="doi">10.3390/ph13120444</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-13-00444</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>From Ethnomedicine to Plant Biotechnology and Machine Learning: The Valorization of the Medicinal Plant <italic>Bryophyllum</italic> sp.</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1798-6235</contrib-id><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>Pascual</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00444">1</xref><xref ref-type="aff" rid="af2-pharmaceuticals-13-00444">2</xref><xref ref-type="author-notes" rid="fn1-pharmaceuticals-13-00444">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Lozano-Milo</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00444">1</xref><xref ref-type="aff" rid="af2-pharmaceuticals-13-00444">2</xref><xref ref-type="author-notes" rid="fn1-pharmaceuticals-13-00444">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2835-8958</contrib-id><name><surname>Landin</surname><given-names>Mariana</given-names></name><xref ref-type="aff" rid="af3-pharmaceuticals-13-00444">3</xref><xref ref-type="aff" rid="af4-pharmaceuticals-13-00444">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4622-1728</contrib-id><name><surname>Gallego</surname><given-names>Pedro P.</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00444">1</xref><xref ref-type="aff" rid="af2-pharmaceuticals-13-00444">2</xref><xref rid="c1-pharmaceuticals-13-00444" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-pharmaceuticals-13-00444"><label>1</label>Applied Plant &#x00026; Soil Biology, Plant Biology and Soil Science Department, Biology Faculty, University of Vigo, E-36310 Vigo, Spain; <email>pasgarcia@uvigo.es</email> (P.G.-P.); <email>elozano@alumnos.uvigo.es</email> (E.L.-M.)</aff><aff id="af2-pharmaceuticals-13-00444"><label>2</label>CITACA&#x02014;Agri-Food Research and Transfer Cluster, University of Vigo, E-32004 Ourense, Spain</aff><aff id="af3-pharmaceuticals-13-00444"><label>3</label>Pharmacology, Pharmacy and Pharmaceutical Technology Department, Grupo I+D Farma (GI-1645), Pharmacy Faculty, University of Santiago, E-15782 Santiago de Compostela, Spain; <email>m.landin@usc.es</email></aff><aff id="af4-pharmaceuticals-13-00444"><label>4</label>Health Research Institute of Santiago de Compostela (IDIS), E-15782 Santiago de Compostela, Spain</aff><author-notes><corresp id="c1-pharmaceuticals-13-00444"><label>*</label>Correspondence: <email>pgallego@uvigo.es</email></corresp><fn id="fn1-pharmaceuticals-13-00444"><label>&#x02020;</label><p>Both authors contributed equally in this manuscript.</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>13</volume><issue>12</issue><elocation-id>444</elocation-id><history><date date-type="received"><day>10</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The subgenus <italic>Bryophyllum</italic> includes about 25 plant species native to Madagascar, and is widely used in traditional medicine worldwide. Different formulations from <italic>Bryophyllum</italic> have been employed for the treatment of several ailments, including infections, gynecological disorders, and chronic diseases, such as diabetes, neurological and neoplastic diseases. Two major families of secondary metabolites have been reported as responsible for these bioactivities: phenolic compounds and bufadienolides. These compounds are found in limited amounts in plants because they are biosynthesized in response to different biotic and abiotic stresses. Therefore, novel approaches should be undertaken with the aim of achieving the phytochemical valorization of <italic>Bryophyllum</italic> sp., allowing a sustainable production that prevents from a massive exploitation of wild plant resources. This review focuses on the study of phytoconstituents reported on <italic>Bryophyllum</italic> sp.; the application of plant tissue culture methodology as a reliable tool for the valorization of bioactive compounds; and the application of machine learning technology to model and optimize the full phytochemical potential of <italic>Bryophyllum</italic> sp. As a result, <italic>Bryophyllum</italic> species can be considered as a promising source of plant bioactive compounds, with enormous antioxidant and anticancer potential, which could be used for their large-scale biotechnological exploitation in cosmetic, food, and pharmaceutical industries.</p></abstract><kwd-group><kwd><italic>Bryophyllum</italic></kwd><kwd>traditional medicine</kwd><kwd>secondary metabolism</kwd><kwd>bioactive and phenolic compounds</kwd><kwd>bufadienolides</kwd><kwd>antioxidants</kwd><kwd>cytotoxic activity</kwd><kwd>plant tissue culture</kwd><kwd>artificial intelligence</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceuticals-13-00444"><title>1. Introduction</title><p>The genus <italic>Kalanchoe</italic> (Adanson, 1736 [<xref rid="B1-pharmaceuticals-13-00444" ref-type="bibr">1</xref>]) belongs to the Crassulaceae family and comprises 150 to 200 succulent species native to Madagascar and naturalized across Africa, South America, and Asia [<xref rid="B2-pharmaceuticals-13-00444" ref-type="bibr">2</xref>,<xref rid="B3-pharmaceuticals-13-00444" ref-type="bibr">3</xref>]. Kalanchoe constitutes a complex genus with an intricate taxonomy, not yet clearly elucidated. Two different trends have been remarkable throughout the published literature concerning both its nomenclature and systematics [<xref rid="B4-pharmaceuticals-13-00444" ref-type="bibr">4</xref>]. Authors disagree whether the classification is based on a single genus called <italic>Kalanchoe</italic> (sensu lato) or three separate sections: <italic>Kalanchoe</italic> (sensu stricto), <italic>Bryophyllum</italic> Kahl. (Salisbury, 1805 [<xref rid="B5-pharmaceuticals-13-00444" ref-type="bibr">5</xref>]), and <italic>Kitchingia</italic> (Baker, 1881 [<xref rid="B6-pharmaceuticals-13-00444" ref-type="bibr">6</xref>]). However, other authors propose a three-subgenera classification of the genus <italic>Kalanchoe</italic>, due to different evolutive arguments, morphological traits [<xref rid="B7-pharmaceuticals-13-00444" ref-type="bibr">7</xref>] and molecular analyses [<xref rid="B8-pharmaceuticals-13-00444" ref-type="bibr">8</xref>], including <italic>Kalanchoe</italic>, <italic>Bryophyllum</italic> and <italic>Calophygia</italic> [<xref rid="B4-pharmaceuticals-13-00444" ref-type="bibr">4</xref>]. Amongst the different subgenera, the subgenus <italic>Bryophyllum</italic> includes around 25 species, endemic to Madagascar [<xref rid="B9-pharmaceuticals-13-00444" ref-type="bibr">9</xref>] that gained much interest on plant science research, as they are considered model plants for different physiological features: the Crassulacean Acid Metabolism (CAM) [<xref rid="B10-pharmaceuticals-13-00444" ref-type="bibr">10</xref>], vegetative reproduction [<xref rid="B11-pharmaceuticals-13-00444" ref-type="bibr">11</xref>], plant cell regeneration [<xref rid="B12-pharmaceuticals-13-00444" ref-type="bibr">12</xref>], and a source of therapeutical compounds [<xref rid="B13-pharmaceuticals-13-00444" ref-type="bibr">13</xref>]. Nevertheless, the most relevant feature associated to this subgenus is the use of their constitutive species in the traditional medicine worldwide, thus considering <italic>Bryophyllum</italic> sp. as medicinal plants, due to their associated bioactivities [<xref rid="B13-pharmaceuticals-13-00444" ref-type="bibr">13</xref>].</p><p>CAM photosynthesis is an advantageous adaptative strategy that enables plant adaptation to arid ecosystems, as it is the case of the whole Kalanchoe genus [<xref rid="B14-pharmaceuticals-13-00444" ref-type="bibr">14</xref>]. <italic>Bryophyllum</italic> species present a flexible CAM regime, with no time restriction on CO<sub>2</sub> uptake, which is fixed at night [<xref rid="B15-pharmaceuticals-13-00444" ref-type="bibr">15</xref>]. On the other hand, <italic>Bryophyllum</italic> sp. present a highly specialized asexual reproductive mechanism, based on the symmetric plantlet development along the leaf margins or leaf tips of adult plants (<xref ref-type="fig" rid="pharmaceuticals-13-00444-f001">Figure 1</xref>) [<xref rid="B12-pharmaceuticals-13-00444" ref-type="bibr">12</xref>,<xref rid="B16-pharmaceuticals-13-00444" ref-type="bibr">16</xref>]. Such clonal-spreading reproductive mechanism is driven by a complex phenomenon that combines both embryogenic and organogenetic events that has not been fully elucidated to date [<xref rid="B17-pharmaceuticals-13-00444" ref-type="bibr">17</xref>,<xref rid="B18-pharmaceuticals-13-00444" ref-type="bibr">18</xref>,<xref rid="B19-pharmaceuticals-13-00444" ref-type="bibr">19</xref>,<xref rid="B20-pharmaceuticals-13-00444" ref-type="bibr">20</xref>,<xref rid="B21-pharmaceuticals-13-00444" ref-type="bibr">21</xref>]. Both the metabolic and reproductive patterns found on <italic>Bryophyllum</italic> sp. contribute to the invasiveness of these species. It allows them a rapid colonization of unexplored territories with high adaptative efficiency, which has contributed to their worldwide naturalization [<xref rid="B22-pharmaceuticals-13-00444" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceuticals-13-00444" ref-type="bibr">23</xref>].</p><p><italic>Bryophyllum</italic> and other Kalanchoe species have been widely used in the traditional medicine of vast regions throughout Africa, South America, and Asia [<xref rid="B24-pharmaceuticals-13-00444" ref-type="bibr">24</xref>]. Because of its wide distribution and ubiquitous medicinal use, much research on this subgenus has focused on <italic>Bryophyllum pinnatum</italic> (Lam.) Oken [<xref rid="B25-pharmaceuticals-13-00444" ref-type="bibr">25</xref>,<xref rid="B26-pharmaceuticals-13-00444" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceuticals-13-00444" ref-type="bibr">27</xref>]; however, there is an extensive variety of other species that have also been exploited in Ethnomedicine, such as: <italic>B. daigremontianum</italic> (Raym.-Hamet et Perr.) Berg. [<xref rid="B28-pharmaceuticals-13-00444" ref-type="bibr">28</xref>], <italic>B. tubiflorum</italic> Harv. [<xref rid="B29-pharmaceuticals-13-00444" ref-type="bibr">29</xref>,<xref rid="B30-pharmaceuticals-13-00444" ref-type="bibr">30</xref>], and <italic>B. &#x000d7; houghtonii</italic> D.B. Ward (syn. <italic>B. daigremontianum &#x000d7; tubiflorum</italic>) [<xref rid="B31-pharmaceuticals-13-00444" ref-type="bibr">31</xref>]. Leaf and root-derived formulations have been mostly used for the treatment of several common illnesses such as burns, wounds, insect bites, skin diseases, cough, fever or several infections, and chronic diseases, such as diabetes, and neurological and neoplastic diseases (<xref rid="pharmaceuticals-13-00444-t001" ref-type="table">Table 1</xref>).</p><p>The great therapeutic potential reported on <italic>Bryophyllum</italic> sp. [<xref rid="B39-pharmaceuticals-13-00444" ref-type="bibr">39</xref>] has promoted in-depth phytochemical analysis to adequately evaluate its biological and pharmacological properties [<xref rid="B55-pharmaceuticals-13-00444" ref-type="bibr">55</xref>,<xref rid="B56-pharmaceuticals-13-00444" ref-type="bibr">56</xref>]. Several authors have demonstrated the whole bioactive potential of <italic>Bryophyllum</italic>-derived extracts, acting as multifaceted agents.</p><p>The anti-inflammatory activity of <italic>Bryophyllum</italic> extracts has been determined by different methods using both in vivo and in vitro models. For instance, aqueous extracts from <italic>B. pinnatum</italic> were shown to exert a relevant effect against croton oil-induced ear edema and carrageenan-induced paw edema in murine models, driven by a decrease in pro-inflammatory cytokines [<xref rid="B57-pharmaceuticals-13-00444" ref-type="bibr">57</xref>]. Moreover, different flavonoids produced by <italic>B. tubiflorum</italic> showed an inhibitory effect on nitric oxide production by lipopolysaccharide-induced macrophage in vitro RAW264.7 cell line [<xref rid="B58-pharmaceuticals-13-00444" ref-type="bibr">58</xref>].</p><p>The antimicrobial activity attributed to <italic>Bryophyllum</italic> extracts was shown to present a high effectiveness against a wide range of both bacterial and fungal activities. In this sense, hydroethanolic extracts from <italic>B. fedtschenkoi</italic> showed a strong inhibitory effect against different antimicrobial resistant strains from the ESKAPE complex, including both Gram-negative and Gram-positive bacteria [<xref rid="B37-pharmaceuticals-13-00444" ref-type="bibr">37</xref>]. Similarly, the bactericidal effect of <italic>B. crenatum</italic> leaf juice against <italic>Bacillus subtilis</italic> and <italic>Klebsiella pneumoniae</italic> was also reported, as well as high effectiveness of methanol extracts from <italic>B. pinnatum</italic> to Gram-positive bacteria [<xref rid="B34-pharmaceuticals-13-00444" ref-type="bibr">34</xref>]. Moreover, different isolated fractions from <italic>B. daigremontianum</italic> ethanolic extracts promoted a potent activity against Safase S-04 yeast strain, fungi, such as <italic>Candida albicans</italic> and <italic>Aspergillus niger</italic>, and bacteria, including <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic> [<xref rid="B59-pharmaceuticals-13-00444" ref-type="bibr">59</xref>]. Furthermore, the antiviral activity of <italic>Bryophyllum</italic> extracts has been also assessed for relevant viral diseases. It is the case of the antiviral activity of kaempferol derivatives from <italic>B. daigremontianum</italic> against Herpes Simplex Virus (HSV) types 1 and 2 [<xref rid="B60-pharmaceuticals-13-00444" ref-type="bibr">60</xref>] and bryophyllin B from <italic>B. pinnatum</italic> as a potent inhibitor of Human Immunodeficiency Virus (HIV) [<xref rid="B61-pharmaceuticals-13-00444" ref-type="bibr">61</xref>].</p><p>Additionally, the analgesic and sedative properties of <italic>Bryophyllum</italic> extracts were evaluated using in vivo murine models, indicating that leaf extracts from <italic>B. crenatum</italic> showed a protective effect against formalin and acetic acid-induced pain and inhibited the manifestation of seizures under convulsant agents application [<xref rid="B32-pharmaceuticals-13-00444" ref-type="bibr">32</xref>].</p><p>The antioxidant properties of <italic>Bryophyllum</italic> extracts have been widely reported by a plethora of different methods. The radical scavenging activity against 2,2-diphenyl-picryl-hydrazyl (DPPH), superoxide anion and nitric oxide of <italic>B. daigremontianum</italic>, <italic>B. tubiflorum</italic>, <italic>B. &#x000d7; houghtonii,</italic> and <italic>B. pinnatum</italic> leaf and aerial part extracts was reported [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>,<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>]. The inhibition of lipid peroxidation by hydromethanolic extracts from aerial parts of <italic>B. daigremontianum</italic>, <italic>B. tubiflorum</italic>, and <italic>B. &#x000d7; houghtonii</italic>, cultured in vitro was also determined [<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>]. Moreover, cell-based in vitro antioxidant assays have been performed for the inhibition of lipid peroxidation of root extracts from <italic>B. daigremontianum</italic> [<xref rid="B24-pharmaceuticals-13-00444" ref-type="bibr">24</xref>].</p><p><italic>Bryophyllum</italic> extracts have been also shown to present insecticidal properties, as a consequence of bufadienolide production, as reviewed later. In this sense, methanolic leaf extracts from <italic>B. daigremontianum</italic>, <italic>B. pinnatum,</italic> and <italic>B. &#x000d7; houghtonii</italic> showed an intense effect against silkworm larvae (<italic>Bombyx mori</italic>) [<xref rid="B65-pharmaceuticals-13-00444" ref-type="bibr">65</xref>,<xref rid="B66-pharmaceuticals-13-00444" ref-type="bibr">66</xref>,<xref rid="B67-pharmaceuticals-13-00444" ref-type="bibr">67</xref>].</p><p>Moreover, cardioprotective and antihypertensive properties were attributed to different <italic>Bryophyllum</italic> sp. [<xref rid="B68-pharmaceuticals-13-00444" ref-type="bibr">68</xref>]. For instance, the aqueous extracts of <italic>B. pinnatum</italic> have been shown to exhibit in vivo antihypertensive activity on high salt-loaded rats models [<xref rid="B69-pharmaceuticals-13-00444" ref-type="bibr">69</xref>]. Furthermore, isolates from <italic>B. daigremontianum</italic> root extracts developed an in vitro anti-thrombotic activity [<xref rid="B70-pharmaceuticals-13-00444" ref-type="bibr">70</xref>].</p><p>Against all the bioactivities associated with <italic>Bryophyllum</italic> sp., the cytotoxic activity gained much interest during the phytochemical characterization of these species [<xref rid="B71-pharmaceuticals-13-00444" ref-type="bibr">71</xref>]. A great variety of in vitro models have been employed for the determination of cytotoxic and anti-cancer activities on different <italic>Bryophyllum</italic> species, whose extracts have been tested against a high number of cancer cell lines [<xref rid="B13-pharmaceuticals-13-00444" ref-type="bibr">13</xref>,<xref rid="B68-pharmaceuticals-13-00444" ref-type="bibr">68</xref>]. Due to the relevance of this bioactivity, the cytotoxic properties of <italic>Bryophyllum</italic> extracts are included during this review.</p><p>Finally, there are additional health-enhancing properties related to <italic>Bryophyllum</italic> sp., as it is the case of hepatoprotective, antidiabetic activities. Thus, the leaf juice and aqueous of <italic>B. pinnatum</italic> showed a marked in vivo hepatoprotective effect on carbon tetrachloride-induced hepatotoxicity in rats [<xref rid="B72-pharmaceuticals-13-00444" ref-type="bibr">72</xref>], as well as hypoglycemic and hypocholesterolemic effects in streptozotocin-induced diabetic rats [<xref rid="B73-pharmaceuticals-13-00444" ref-type="bibr">73</xref>].</p><p>As a result, the combination of all bioactivities attributed to <italic>Bryophyllum</italic> sp. aroused the interest in the study of their great therapeutic potential, which is a challenge, as it is an unexplored subgenus with countless potential as a health promoter. This is a systematic review in which general search engines, including PubMed, the Web of Science, and Google Scholar were employed, according to Preferred Reported Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.</p></sec><sec id="sec2-pharmaceuticals-13-00444"><title>2. <italic>Bryophyllum</italic> sp. Secondary Metabolites as Antioxidants and Anticancer Agents</title><p>It is now well-known that the full set of bioactivities attributed to <italic>Bryophyllum</italic> sp. is developed by a plethora of phytoconstituents, including phenolic compounds, bufadienolides, organic salts, terpenoids and fatty acids [<xref rid="B55-pharmaceuticals-13-00444" ref-type="bibr">55</xref>]. Phytoconstituents are considered secondary metabolites, since they are biosynthesized by induction of secondary metabolism, which is responsible for the defensive and adaptative plant response against environmental threads and biotic stress [<xref rid="B74-pharmaceuticals-13-00444" ref-type="bibr">74</xref>,<xref rid="B75-pharmaceuticals-13-00444" ref-type="bibr">75</xref>]. Phenolic compounds and bufadienolides are considered the two main families of secondary metabolites of <italic>Bryophyllum</italic> sp., widely distributed throughout the subgenus [<xref rid="B13-pharmaceuticals-13-00444" ref-type="bibr">13</xref>]. Furthermore, they are responsible for the bioactivity associated with <italic>Bryophyllum</italic> sp. and, consequently, a deeper insight into these compounds will be provided.</p><sec id="sec2dot1-pharmaceuticals-13-00444"><title>2.1. Phenolic Compounds</title><p>Two major subfamilies of phenolic compounds have been widely reported for <italic>Bryophyllum</italic> sp.: phenolic acids and flavonoids [<xref rid="B76-pharmaceuticals-13-00444" ref-type="bibr">76</xref>,<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>], which have been recently found to accumulate inside highly specialized leaf cells, called idioblasts [<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>].</p><p>The antioxidant activity of <italic>Bryophyllum</italic> phenolic compounds, focused on the free-radical scavenging activity, has been largely determined [<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B79-pharmaceuticals-13-00444" ref-type="bibr">79</xref>]. Recently, the antioxidant capacity of <italic>Bryophyllum</italic> extracts for preventing the lipid oxidation of omega-3 enriched fish oil emulsions was reported, thus conferring a valuable approach for the application of <italic>Bryophyllum</italic>-derived by-products in the food and pharmacological industries [<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>]. In the same way, the polyphenols from <italic>Bryophyllum</italic>-derived extracts may be efficiently purified using environmental-friendly procedures, like the use of activated carbon [<xref rid="B80-pharmaceuticals-13-00444" ref-type="bibr">80</xref>]. These approaches have been developed in order to allow the industrial exploitation of <italic>Bryophyllum</italic> polyphenols, due to the increasing interest in the research of these medicinal plants.</p><p>The great diversity of bioactivities described for these compounds places the phenolic compounds of <italic>Bryophyllum</italic> sp. as one of the main families of plant secondary metabolites that boost the phytochemical potential of this subgenus [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>,<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>,<xref rid="B81-pharmaceuticals-13-00444" ref-type="bibr">81</xref>].</p><sec id="sec2dot1dot1-pharmaceuticals-13-00444"><title>2.1.1. Phenolic Acids</title><p>Three species of <italic>Bryophyllum</italic> present high content in phenolic acids: <italic>B. pinnatum</italic>, <italic>B. daigremontianum,</italic> and <italic>B. tubiflorum</italic>, mostly located in leaf tissues (<xref rid="pharmaceuticals-13-00444-t002" ref-type="table">Table 2</xref>) [<xref rid="B76-pharmaceuticals-13-00444" ref-type="bibr">76</xref>,<xref rid="B82-pharmaceuticals-13-00444" ref-type="bibr">82</xref>]. Both subfamilies of phenolic acids have identified compounds in either free or glycosylated forms. Caffeic acid and ferulic acid are the most abundant cinnamic acids, while within the benzoic acids it is protocatechuic acid. &#x003b2;-resorcylic and &#x003b3;-rosorcylic acids have also been referenced, although these are more unusual. [<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>].</p><p>Concerning bioactivities, phenolic acids are considered powerful antioxidants whose activity depends on the number, position, and combination of hydroxyl groups within their structure [<xref rid="B83-pharmaceuticals-13-00444" ref-type="bibr">83</xref>]. Potential therapeutic properties for them have also been reported, as they promote antimicrobial, antiviral, cytotoxic, and anti-inflammatory activities [<xref rid="B84-pharmaceuticals-13-00444" ref-type="bibr">84</xref>,<xref rid="B85-pharmaceuticals-13-00444" ref-type="bibr">85</xref>,<xref rid="B86-pharmaceuticals-13-00444" ref-type="bibr">86</xref>,<xref rid="B87-pharmaceuticals-13-00444" ref-type="bibr">87</xref>]. Phenolic acids from <italic>Bryophyllum</italic>-derived extracts have already been related to the development of antibacterial and antifungal activity against a series of pathogenic microorganisms [<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>], antioxidant activity, and cytotoxicity against human lymphoblastic leukemia J45 and H9 T-cell lines [<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>].</p></sec><sec id="sec2dot1dot2-pharmaceuticals-13-00444"><title>2.1.2. Flavonoids</title><p>Flavonoids are universally found in <italic>Bryophyllum</italic> sp. in <italic>O</italic>-glycosylated form. To a large extent, they have been reported in three species, namely: <italic>B. pinnatum</italic>, <italic>B. daigremontianum</italic> and <italic>B. tubiflorum</italic> (<xref rid="pharmaceuticals-13-00444-t003" ref-type="table">Table 3</xref>). The flavonol glycosides were shown as the most abundant subfamily of flavonoids, showing a restricted accumulation on leaf tissues [<xref rid="B13-pharmaceuticals-13-00444" ref-type="bibr">13</xref>,<xref rid="B76-pharmaceuticals-13-00444" ref-type="bibr">76</xref>,<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>]. Both kaempferol and quercetin glycosides were found in <italic>Bryophyllum</italic> species [<xref rid="B39-pharmaceuticals-13-00444" ref-type="bibr">39</xref>,<xref rid="B94-pharmaceuticals-13-00444" ref-type="bibr">94</xref>,<xref rid="B95-pharmaceuticals-13-00444" ref-type="bibr">95</xref>]. Other flavonoid subfamilies, such as flavones and catechins, have also been reported, and a number of anthocyanins have been isolated from the flowers of different species [<xref rid="B39-pharmaceuticals-13-00444" ref-type="bibr">39</xref>,<xref rid="B96-pharmaceuticals-13-00444" ref-type="bibr">96</xref>], which are stored in the foliar idioblasts of <italic>B. daigremontianum</italic> [<xref rid="B82-pharmaceuticals-13-00444" ref-type="bibr">82</xref>] and <italic>B. tubiflorum</italic> [<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>].</p><p>The antioxidant activity of flavonoids is directly proportional to the number and position of hydroxyl groups in their structure [<xref rid="B97-pharmaceuticals-13-00444" ref-type="bibr">97</xref>], that assist in the dissipation of electrons generated after UV-overexposure [<xref rid="B98-pharmaceuticals-13-00444" ref-type="bibr">98</xref>]. Additionally, they also prevent lipid peroxidation [<xref rid="B99-pharmaceuticals-13-00444" ref-type="bibr">99</xref>] (by decomposing lipid peroxides and scavenging harmful free-radicals) and develop an effective metal chelation activity [<xref rid="B100-pharmaceuticals-13-00444" ref-type="bibr">100</xref>]. The free-radical scavenging [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>,<xref rid="B101-pharmaceuticals-13-00444" ref-type="bibr">101</xref>,<xref rid="B102-pharmaceuticals-13-00444" ref-type="bibr">102</xref>] and lipid oxidation preventing activities [<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>] of <italic>Bryophyllum</italic>-derived extracts rich in flavonoids have already been reported. Other bioactivities, such as antibacterial [<xref rid="B103-pharmaceuticals-13-00444" ref-type="bibr">103</xref>], antiviral [<xref rid="B104-pharmaceuticals-13-00444" ref-type="bibr">104</xref>], cytotoxic [<xref rid="B105-pharmaceuticals-13-00444" ref-type="bibr">105</xref>], anti-inflammatory [<xref rid="B106-pharmaceuticals-13-00444" ref-type="bibr">106</xref>], cardioprotective [<xref rid="B107-pharmaceuticals-13-00444" ref-type="bibr">107</xref>], sedative and anti-diabetic activities [<xref rid="B108-pharmaceuticals-13-00444" ref-type="bibr">108</xref>] have been associated to flavonoids. These bioactivities have been extensively studied for <italic>Bryophyllum</italic> sp. and have also been related to flavonoid content, mainly using <italic>B. pinnatum</italic> as a plant model [<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceuticals-13-00444" ref-type="bibr">89</xref>,<xref rid="B94-pharmaceuticals-13-00444" ref-type="bibr">94</xref>,<xref rid="B95-pharmaceuticals-13-00444" ref-type="bibr">95</xref>,<xref rid="B109-pharmaceuticals-13-00444" ref-type="bibr">109</xref>,<xref rid="B110-pharmaceuticals-13-00444" ref-type="bibr">110</xref>].</p></sec></sec><sec id="sec2dot2-pharmaceuticals-13-00444"><title>2.2. Bufadienolides</title><p>Bufadienolides constitute a subfamily within cardiac glycosides family of secondary metabolites and they are considered polyhydroxy C-24 steroids, presenting an &#x003b1;-pyrone ring at the C-17&#x003b2; position (<xref ref-type="fig" rid="pharmaceuticals-13-00444-f002">Figure 2</xref>) [<xref rid="B113-pharmaceuticals-13-00444" ref-type="bibr">113</xref>]. Bufadienolides presence in <italic>Bryophyllum</italic> species is genotype and organ dependent [<xref rid="B68-pharmaceuticals-13-00444" ref-type="bibr">68</xref>], being four species the most representative sources of these compounds: <italic>B. daigremontianum</italic>, <italic>B. &#x000d7; houghtonii</italic>, <italic>B. tubiflorum,</italic> and <italic>B. pinnatum</italic> (<xref rid="pharmaceuticals-13-00444-t004" ref-type="table">Table 4</xref>). Universally-distributed bufadienolides, such as bersaldegenin and bryophyllin derivatives [<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>,<xref rid="B114-pharmaceuticals-13-00444" ref-type="bibr">114</xref>], can be found together with genotype-specific compounds, such as kalanchosides [<xref rid="B115-pharmaceuticals-13-00444" ref-type="bibr">115</xref>] and kalanhybrins [<xref rid="B71-pharmaceuticals-13-00444" ref-type="bibr">71</xref>].</p><p>As cardiac glycosides, the original bioactivity attributed to bufadienolides is their cardiotonic activity, acting as inhibitors of the sodium pump at the myocardial tissue [<xref rid="B116-pharmaceuticals-13-00444" ref-type="bibr">116</xref>]. However, its reduced therapeutic window conditions its efficacy, allowing eventual cardiotoxic events due to overdosage [<xref rid="B117-pharmaceuticals-13-00444" ref-type="bibr">117</xref>]. In fact, the accidental consumption of <italic>Bryophyllum</italic> species by different mammals is one of the leading causes of cattle mortality in Africa [<xref rid="B118-pharmaceuticals-13-00444" ref-type="bibr">118</xref>], with reporting episodes of stroke, subendocardial hemorrhages, and heart tissue necrosis [<xref rid="B119-pharmaceuticals-13-00444" ref-type="bibr">119</xref>]. The biosynthesis of bufadienolides is a plant defensive mechanism against insect and herbivore attacks. They have already been reported as effective insecticidal compounds [<xref rid="B31-pharmaceuticals-13-00444" ref-type="bibr">31</xref>].</p><p>Bufadienolides have also been described as potent anticancer agents, as demonstrated by a number of in vitro studies with multiple cancer cell lines (<xref rid="pharmaceuticals-13-00444-t004" ref-type="table">Table 4</xref>) [<xref rid="B120-pharmaceuticals-13-00444" ref-type="bibr">120</xref>]. Nevertheless, their inherent toxicity difficult their administration in animal and human models [<xref rid="B121-pharmaceuticals-13-00444" ref-type="bibr">121</xref>]. Current research on these compounds is focused on finding effective and safer semi-synthetic derivatives [<xref rid="B122-pharmaceuticals-13-00444" ref-type="bibr">122</xref>].</p><p><xref rid="pharmaceuticals-13-00444-t004" ref-type="table">Table 4</xref> shows the associated bioactivities of identified bufadienolides in <italic>Bryophyllum</italic> sp., with a special focus on the cytotoxic activity of these compounds, being effective against relevant cancer cell lines, mainly those derived from breast, ovarian and lung carcinomas [<xref rid="B71-pharmaceuticals-13-00444" ref-type="bibr">71</xref>,<xref rid="B115-pharmaceuticals-13-00444" ref-type="bibr">115</xref>].</p><p>The bioactivity of phenolic and bufadienolides compounds reveals an unexploited phytochemical potential associated with <italic>Bryophyllum</italic> sp. However, research on these secondary metabolites is still very limited, since their concentration and activity depend on adaptive responses of plants, which is why low-yield extraction protocols have been reported [<xref rid="B61-pharmaceuticals-13-00444" ref-type="bibr">61</xref>,<xref rid="B123-pharmaceuticals-13-00444" ref-type="bibr">123</xref>]. Consequently, in order to explore the phytochemical properties of these medicinal plants, the establishment of efficient biotechnological approaches is required to achieve the valorization of <italic>Bryophyllum</italic> subgenus.</p></sec></sec><sec id="sec3-pharmaceuticals-13-00444"><title>3. Plant Tissue Culture for Sustainable Valorization of Bioactive Compounds of <italic>Bryophyllum</italic> sp.</title><p>Currently, medicinal plants represent the source of more than 25% of drugs officially approved by the Food and Drug Administration (FDA) and the European Medicinal Agency (EMA) for the development of novel synthetic drugs [<xref rid="B128-pharmaceuticals-13-00444" ref-type="bibr">128</xref>]. Their derived by-products account for the 75&#x02013;90% of the total used in the primary healthcare systems of economically developed nations [<xref rid="B129-pharmaceuticals-13-00444" ref-type="bibr">129</xref>]. However, only 6% of the plants have been studied from the pharmacological point of view and for 85% of them their phytochemical potential has not been evaluated [<xref rid="B130-pharmaceuticals-13-00444" ref-type="bibr">130</xref>], which represents a vast territory of families of plants with medicinal properties unexplored, such as <italic>Bryophyllum</italic> sp. Novel strategies, based on plant biotechnology methodologies, are required to meet the growing global demand for products derived from medicinal plants for industrial purposes in different sectors, such as the food, cosmetic, and pharmaceutical industries [<xref rid="B131-pharmaceuticals-13-00444" ref-type="bibr">131</xref>].</p><p>Since then, plant biotechnology has constantly evolved, and it currently provides a reliable methodology for the bioproduction of secondary metabolites with pharmacological value, by using plant in vitro systems [<xref rid="B132-pharmaceuticals-13-00444" ref-type="bibr">132</xref>]. Consequently, plant tissue culture (PTC) became a basic biotechnological methodology with countless applications in different areas of knowledge [<xref rid="B133-pharmaceuticals-13-00444" ref-type="bibr">133</xref>]. However, PTC must face its own limitations, as it involves a set of highly specialized, usually expensive, techniques that are extremely sensitive to multiple factors [<xref rid="B134-pharmaceuticals-13-00444" ref-type="bibr">134</xref>]. In this section, we will provide a deeper insight about the key aspects of PTC, with particular focus on the methodology applied to <italic>Bryophyllum</italic> sp. (<xref ref-type="fig" rid="pharmaceuticals-13-00444-f003">Figure 3</xref>).</p><sec id="sec3dot1-pharmaceuticals-13-00444"><title>3.1. PTC Establishment</title><p>The first step of a PTC protocol is the effective removal of pathogenic contaminants from the selected plant material (<xref ref-type="fig" rid="pharmaceuticals-13-00444-f003">Figure 3</xref>) [<xref rid="B135-pharmaceuticals-13-00444" ref-type="bibr">135</xref>]. Therefore, the sterilization of the explant surface is required through a procedure that ensures convenient disinfection while maintaining its integrity, along with aseptic handling in laminar flow cabinets [<xref rid="B136-pharmaceuticals-13-00444" ref-type="bibr">136</xref>].</p><p>In particular, our research group has developed a simple and reliable method for the disinfection of epiphyllous buds of the adult plants of <italic>B. daigremontianum</italic>, <italic>B. &#x000d7; houghtonii</italic> and <italic>B. tubiflorum</italic> species grown in greenhouse, which involves the use of common, safe and environmental-friendly disinfectant agents [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>,<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>,<xref rid="B80-pharmaceuticals-13-00444" ref-type="bibr">80</xref>,<xref rid="B101-pharmaceuticals-13-00444" ref-type="bibr">101</xref>,<xref rid="B137-pharmaceuticals-13-00444" ref-type="bibr">137</xref>]. The protocol includes an initial tap water wash of the buds overnight, followed by a two-step stage, where the buds are rinsed in 70% ethanol (<italic>v</italic>/<italic>v</italic>) for 1 min, washed with sterile distilled water and then rinsed in 0.4% (<italic>v</italic>/<italic>v</italic>) sodium hypochlorite with a few drops of Tween<sup>&#x000ae;</sup>-20 for 10 min. Finally, buds are gently washed with sterile distilled water and dried to remove persistent residues of disinfection agents. After the establishment under aseptic conditions, disinfected buds are placed and cultured in growth chambers under controlled conditions of photoperiod and temperature, thus enabling an adequate culture development. This procedure represents an improvement on the previously established disinfection protocols for <italic>Bryophyllum</italic> sp., in which slower procedures were performed [<xref rid="B138-pharmaceuticals-13-00444" ref-type="bibr">138</xref>] with more concentrated disinfectants [<xref rid="B139-pharmaceuticals-13-00444" ref-type="bibr">139</xref>]; with greater losses of viability [<xref rid="B140-pharmaceuticals-13-00444" ref-type="bibr">140</xref>] and explants integrity [<xref rid="B141-pharmaceuticals-13-00444" ref-type="bibr">141</xref>], or with more polluting agents, such as mercury chloride [<xref rid="B142-pharmaceuticals-13-00444" ref-type="bibr">142</xref>].</p><sec><title>Plant Culture Media Composition</title><p>Plant culture media composition plays a crucial role in the success of PTC protocols, as the nutrition of cultured plant materials depends directly on its ingredients [<xref rid="B143-pharmaceuticals-13-00444" ref-type="bibr">143</xref>]. As a general rule, plant culture medium formulations contain a series of inorganic nutrients, divided into macro- and micronutrients according to their requirements for plant physiology, along with organic nutrients, such as vitamins [<xref rid="B144-pharmaceuticals-13-00444" ref-type="bibr">144</xref>]. Among the countless culture media formulations defined in PTC protocols, the formulation described by Murashige and Skoog in 1962 [<xref rid="B145-pharmaceuticals-13-00444" ref-type="bibr">145</xref>], mostly known as MS medium, is considered the universal medium to be applied as standard for different plant biotechnological applications [<xref rid="B146-pharmaceuticals-13-00444" ref-type="bibr">146</xref>]. The universality of the MS medium is based on its high levels of nitrogen sources, with a relatively high ratio of ammonium to nitrate [<xref rid="B147-pharmaceuticals-13-00444" ref-type="bibr">147</xref>]. However, it has recently been pointed out that the composition of the MS medium is supra-optimal for some species and therefore harmful due to an excessive concentration of ammonium ions [<xref rid="B148-pharmaceuticals-13-00444" ref-type="bibr">148</xref>,<xref rid="B149-pharmaceuticals-13-00444" ref-type="bibr">149</xref>].</p><p><italic>Bryophyllum</italic> sp. are especially affected by excess of ammonium ion. This cation negatively affects the growth of these species, due to a deterioration of CAM photosynthetic efficiency [<xref rid="B150-pharmaceuticals-13-00444" ref-type="bibr">150</xref>,<xref rid="B151-pharmaceuticals-13-00444" ref-type="bibr">151</xref>]. Although PTC of <italic>Bryophyllum</italic> sp. has been established using MS medium [<xref rid="B138-pharmaceuticals-13-00444" ref-type="bibr">138</xref>,<xref rid="B139-pharmaceuticals-13-00444" ref-type="bibr">139</xref>], better growth and multiplication rates were achieved when the composition of the MS medium was modified, as it has been shown by reducing the concentration of macronutrients by half for <italic>B. daigremontianum</italic>, <italic>B. &#x000d7; houghtonii</italic> and <italic>B. tubiflorum</italic> [<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>,<xref rid="B80-pharmaceuticals-13-00444" ref-type="bibr">80</xref>,<xref rid="B101-pharmaceuticals-13-00444" ref-type="bibr">101</xref>].</p></sec></sec><sec id="sec3dot2-pharmaceuticals-13-00444"><title>3.2. Organogenesis and Plant Regeneration</title><p>Thus far, the information on the plant regeneration protocols for <italic>Bryophyllum</italic> sp. is limited. Most publications focus on the establishment of indirect regeneration protocols [<xref rid="B138-pharmaceuticals-13-00444" ref-type="bibr">138</xref>,<xref rid="B139-pharmaceuticals-13-00444" ref-type="bibr">139</xref>,<xref rid="B140-pharmaceuticals-13-00444" ref-type="bibr">140</xref>,<xref rid="B141-pharmaceuticals-13-00444" ref-type="bibr">141</xref>,<xref rid="B152-pharmaceuticals-13-00444" ref-type="bibr">152</xref>]. Recently, we have provided information on the effect of exogenous application of plant growth regulators (PGRs) on the in vitro organogenesis of <italic>B. daigremontianum</italic>, <italic>B. &#x000d7; houghtonii</italic> and <italic>B. tubiflorum</italic> [<xref rid="B137-pharmaceuticals-13-00444" ref-type="bibr">137</xref>], pointing at the concentration of the cytokinin 6-benzylaminopurine (BAP) as the most critical factor guiding this process. Specifically, it was demonstrated that at operational concentrations of BAP (0.375&#x02013;0.75 mg L<sup>&#x02212;1</sup>) both <italic>B. daigremontianum</italic> and <italic>B. &#x000d7; houghtonii</italic> present a higher frequency of direct shoot regeneration than <italic>B. tubiflorum</italic>. In turn, <italic>B. tubiflorum</italic> was revealed as the most efficient species for the induction of callus formation during indirect organogenesis [<xref rid="B137-pharmaceuticals-13-00444" ref-type="bibr">137</xref>]. These results highlight the complexity of the design of plant in vitro regeneration protocols and shed light into the organogenesis-related processes of <italic>Bryophyllum</italic> sp., facing to the large-scale exploitation of these medicinal plants.</p></sec><sec id="sec3dot3-pharmaceuticals-13-00444"><title>3.3. Micropropagation</title><p>After the establishment of axenic cultures, PTC protocols normally are followed by multiplication, rooting and acclimatization stages, throughout the procedure called micropropagation (<xref ref-type="fig" rid="pharmaceuticals-13-00444-f003">Figure 3</xref>), with the objective of achieving a large number of fully-developed true-to-type individuals [<xref rid="B135-pharmaceuticals-13-00444" ref-type="bibr">135</xref>]. The singular asexual reproduction that takes place at leaf margins of <italic>Bryophyllum</italic>, results in the clonal propagation of fully-developed epiphyllous buds, presenting individual aerial and root systems [<xref rid="B11-pharmaceuticals-13-00444" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceuticals-13-00444" ref-type="bibr">12</xref>]. For this reason, <italic>Bryophyllum</italic> constitutes an outstanding subgenus for the micropropagation of different species. Nevertheless, the micropropagation of <italic>Bryophyllum</italic> is not exempt from difficulties due to its particular metabolism and poor nutritional requirements [<xref rid="B151-pharmaceuticals-13-00444" ref-type="bibr">151</xref>]. In this sense, it was recently reported that ammonium, sulfur, molybdenum, copper, and sodium play a crucial role on growth and plantlet formation on in vitro-cultured <italic>Bryophyllum</italic> in a species-dependent manner [<xref rid="B153-pharmaceuticals-13-00444" ref-type="bibr">153</xref>]. Therefore, multiple nutritional modifications may be required to achieve genotype-specific optimization, since mineral imbalances and interactions could directly influence the success of PTC protocols, by affecting micropropagation performance [<xref rid="B154-pharmaceuticals-13-00444" ref-type="bibr">154</xref>], and causing undesirable physiological disorders [<xref rid="B148-pharmaceuticals-13-00444" ref-type="bibr">148</xref>].</p></sec><sec id="sec3dot4-pharmaceuticals-13-00444"><title>3.4. Establishment of Plant Suspension-Cultured Cells (PSCCs)</title><p>In the last decades, an increasing interest of plant biotechnology has been addressed to the evaluation and valorization of medicinal plants, with the aim of exploring their phytochemical potential and making it accessible to industrial applications [<xref rid="B155-pharmaceuticals-13-00444" ref-type="bibr">155</xref>]. In order to maximize the advantages of PTC for the production of secondary metabolites, plant suspension-cultured cells (PSCCs) emerged as a valuable biotechnological platform [<xref rid="B156-pharmaceuticals-13-00444" ref-type="bibr">156</xref>].</p><p>A single recent report is available for the establishment of PSCCs from <italic>B. &#x000d7; houghtonii</italic> [<xref rid="B101-pharmaceuticals-13-00444" ref-type="bibr">101</xref>]. In this work, the use of PSCCs from <italic>B. &#x000d7; houghtonii</italic> for the production of bioactive compounds was reported, with a special focus on the operational aspects required for the establishment of plant cell cultures, such as the determination of growth kinetics [<xref rid="B101-pharmaceuticals-13-00444" ref-type="bibr">101</xref>]. The typical four-phase growth behavior was reported only after 8 days of culture, starting with an initial lag phase where cells acclimatize to new culture conditions and no growth is observed. The lag phase is followed by the exponential phase, where cell divisions occur massively, reported by a severe increase in cell biomass. Afterward, a stationary phase is reached: cell growth stabilizes and the accumulation of secondary metabolites is observed, before reaching death phase, in which cell death takes place due to a lack of nutrients [<xref rid="B157-pharmaceuticals-13-00444" ref-type="bibr">157</xref>].</p><p>PSCCs are considered a valuable biological platform for the application of several approaches to enhance plant secondary metabolism, which have been widely exploited in the field of plant biotechnology for the production of bioactive compounds: elicitation, precursor feeding, two-phase culture system, and metabolic engineering [<xref rid="B158-pharmaceuticals-13-00444" ref-type="bibr">158</xref>]. Among them, elicitation is the most extended approach applied to PSCCs, although it can be applied to many other culture types [<xref rid="B159-pharmaceuticals-13-00444" ref-type="bibr">159</xref>]. Due to the importance of elicitation on the evaluation of medicinal plants and their phytochemical potential, the next section will be focused on this phenomenon, with a particular focus on the elicitation of <italic>Bryophyllum</italic> sp.</p></sec><sec id="sec3dot5-pharmaceuticals-13-00444"><title>3.5. Enhancement of Phenolic Compounds Production from Bryophyllum sp. via Elicitation</title><p>In the last years, great efforts regarding the improvement of plant secondary metabolism have been made in the field of plant biotechnology, being the elicitation of PSCCs one of the most successful approaches applied for the large-scale production of plant bioactive compounds [<xref rid="B160-pharmaceuticals-13-00444" ref-type="bibr">160</xref>]. A review of the literature shows that the number of publications selected by Google Scholar<sup>&#x000ae;</sup> from the search &#x0201c;elicitation of plant cell culture&#x0201d; is close to 15,000 entries in the last five years.</p><p>The term elicitation, as recently defined by Narayani and Srivastava (2017) [<xref rid="B161-pharmaceuticals-13-00444" ref-type="bibr">161</xref>], refers to &#x0201c;the manipulation of biochemical and metabolic pathways, via stress induction, that can be implemented for enhancing secondary metabolite production and characterize the role of stress factors on plants using plant cell and/or tissue cultures as model systems&#x0201d;. On this basis, different types of culture may constitute precious biological platforms for the stimulation of plant secondary metabolism under controlled conditions, by the administration of elicitors (<xref ref-type="fig" rid="pharmaceuticals-13-00444-f003">Figure 3</xref>). In all cases, obtaining the maximum viability and integrity of the elicited cultures is required in order to achieve an efficient and sustainable production system [<xref rid="B162-pharmaceuticals-13-00444" ref-type="bibr">162</xref>].</p><p>Little information about the elicited production of bioactive compounds by <italic>Bryophyllum</italic> sp. can be found in the literature. Recently, the elicitation of phenolic compounds from in vitro-cultured <italic>Bryophyllum</italic> sp. subjected to nutritional stress has been reported by Garc&#x000ed;a-P&#x000e9;rez and co-workers (2020) [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>]. It was found that a decrease in the ammonium concentration in the culture medium causes a 50% overproduction and accumulation of phenolic compounds in the aerial parts of <italic>B. &#x000d7; houghtonii</italic>. The effect was less in magnitude in <italic>B. daigremontianum</italic> and <italic>B. tubiflorum</italic> [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>]. In addition, the antioxidant efficiency of the derived <italic>Bryophyllum</italic> extracts was assessed in terms of their free-radical scavenging activity and lipid peroxidation inhibition [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>,<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>], suggesting that in vitro-cultured <italic>B. &#x000d7; houghtonii</italic> can be considered a medicinal species with an improved phytochemical potential [<xref rid="B80-pharmaceuticals-13-00444" ref-type="bibr">80</xref>], in comparison to closely-related species, such as <italic>B. daigremontianum</italic> and <italic>B. tubiflorum</italic>. In this sense, due to its phytochemical potential, PSCCs from <italic>B. &#x000d7; houghtonii</italic> were subjected to elicitation by cyclodextrins (CDs) [<xref rid="B101-pharmaceuticals-13-00444" ref-type="bibr">101</xref>]. CDs are cyclic oligosaccharides able of forming inclusion complexes with hydrophobic molecules. The results suggested that CDs elicited the production of phenolic compounds in <italic>Bryophyllum</italic> PSCCs, as well as their associated free-radical scavenging activity. Specifically, it was shown that CDs favored the accumulation of total phenols and flavonoids in the culture medium (7.9 and 17.3-fold increases, respectively) after 7 days of culture, thus, preserving the integrity of the cellular fraction for subsequent elicitation cycles [<xref rid="B101-pharmaceuticals-13-00444" ref-type="bibr">101</xref>].</p><p>Altogether, the application of novel approaches should be developed in order to reveal the full phytochemical potential of <italic>Bryophyllum</italic> sp., based on the application of unexploited PTC strategies, taking benefit of the countless advantages provided by PSCCs, committed to the enhancement of plant secondary metabolite production.</p></sec></sec><sec id="sec4-pharmaceuticals-13-00444"><title>4. Machine Learning for Optimizing the Biotechnological Valorization of <italic>Bryophyllum</italic> sp.</title><p>Along with this review, we provided evidence about the multifactorial behavior of PTC methodologies and the production of secondary metabolites (<xref ref-type="fig" rid="pharmaceuticals-13-00444-f003">Figure 3</xref>). Therefore, the elucidation and characterization of such phenomena may require the development of complex experimental designs, to reveal relevant interactions between factors, which are not feasible due to cost and time. Furthermore, the analysis and interpretation of these complex experimental designs is difficult and, in many cases, limited or incomplete [<xref rid="B163-pharmaceuticals-13-00444" ref-type="bibr">163</xref>].</p><p>Machine Learning (ML) techniques stand out as a cutting-edge alternative to detect the critical factors behind a certain procedure, as well as a method to establish the influence of possible interactions between them [<xref rid="B164-pharmaceuticals-13-00444" ref-type="bibr">164</xref>]. The application of ML algorithms allows the modeling of complex processes, a powerful tool for making decisions and studying unknown phenomena [<xref rid="B165-pharmaceuticals-13-00444" ref-type="bibr">165</xref>]. Among the different ML tools, the combination of artificial neural networks with fuzzy logic, commonly known as neuro-fuzzy logic (NFL), constitutes a robust computational tool for the optimization and prediction of complex processes [<xref rid="B166-pharmaceuticals-13-00444" ref-type="bibr">166</xref>]. Furthermore, NFL offers another advantage regarding the efficacy of predictive models, thus providing direct knowledge from a detailed interpretation of the results, by the establishment of simple &#x0201c;IF-THEN&#x0201d; rules, that facilitate making conclusions [<xref rid="B167-pharmaceuticals-13-00444" ref-type="bibr">167</xref>].</p><p>Concerning <italic>Bryophyllum</italic> sp., the application of NFL was already applied to the identification of critical factors involved in plant in vitro nutrition [<xref rid="B153-pharmaceuticals-13-00444" ref-type="bibr">153</xref>] and organogenesis [<xref rid="B137-pharmaceuticals-13-00444" ref-type="bibr">137</xref>], as well as the production of phenolic compounds [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>].</p><p>In this sense, ML was able to identify the key mineral nutrients and their interactions, in order to optimize the growth and reproduction of <italic>Bryophyllum</italic> sp. cultured in vitro. Among the 18 different mineral nutrients used on MS formulation, ML detected that only five nutrients were critical on <italic>Bryophyllum</italic> in vitro culture, in a genotype-dependent manner [<xref rid="B153-pharmaceuticals-13-00444" ref-type="bibr">153</xref>]. Specifically, ammonium, sulfate, sodium, molybdenum, and copper were selected by NFL as the critical factors guiding several growth-related parameters, and the interaction between sulfate and molybdenum was widely reported as responsible for most parameters: root length, plantlet formation, and aerial parts fresh weight [<xref rid="B153-pharmaceuticals-13-00444" ref-type="bibr">153</xref>].</p><p>ML was also employed for the modeling and predicting of <italic>Bryophyllum</italic> organogenesis in vitro [<xref rid="B137-pharmaceuticals-13-00444" ref-type="bibr">137</xref>]. BAP concentration was assessed as the critical factor guiding this phenomenon on B. daigremontianum, B. &#x000d7; houghtonii and B. tubiflorum; thus, predicting a minimal BAP concentration required for the development of different organogenetic responses (0.35 mg L<sup>&#x02212;1</sup>). On the contrary, the application of auxins, such as indoleacetic acid (IAA), was outlined as an inhibitory factor on the indirect shoot regeneration on B. tubiflorum, whereas no IAA influence was reported on <italic>B. daigremontianum</italic> and <italic>B. &#x000d7; houghtonii</italic> [<xref rid="B137-pharmaceuticals-13-00444" ref-type="bibr">137</xref>].</p><p>Additionally, the production of phenolic compounds by in vitro-cultured <italic>Bryophyllum</italic> sp. was optimized using ML [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>]. It was observed that phenolic compounds accumulation achieved the maximum concentrations in the aerial parts of cultured plants under low ammonium concentrations (&#x0003c;15 mM). Moreover, the extraction of total phenolic compounds was enhanced by the use of 55&#x02013;85% aqueous methanol, whereas flavonoids were mostly extracted with higher methanol concentrations in water (&#x0003e;85%). In addition, the antioxidant potential of <italic>Bryophyllum</italic> extracts, in terms of radical-scavenging activity, was shown to be improved using 55&#x02013;85% MeOH as solvent on <italic>B. &#x000d7; houghtonii</italic> cultured under low ammonium concentrations [<xref rid="B62-pharmaceuticals-13-00444" ref-type="bibr">62</xref>]. Furthermore, these experimental conditions for maximizing the antioxidant activity of <italic>B. &#x000d7; houghtonii</italic> were also validated in terms of preventing lipid oxidation [<xref rid="B64-pharmaceuticals-13-00444" ref-type="bibr">64</xref>] and plant in vitro growth [<xref rid="B153-pharmaceuticals-13-00444" ref-type="bibr">153</xref>]; thus, assessing the effectiveness of ML on the valorization of <italic>Bryophyllum</italic>.</p></sec><sec id="sec5-pharmaceuticals-13-00444"><title>5. Concluding Remarks and Future Perspectives</title><p>This review focuses on the ethnomedicinal uses of <italic>Bryophyllum</italic> sp., and their main phytoconstituents, responsible for its biological and pharmacological properties (cytotoxic, sedative, insecticidal, antiviral, and anticancer activities).</p><p>It has also been described how the development of optimal methods of plant tissue culture for <italic>Bryophyllum</italic> sp. can lead to the valorization of the bioactive compounds of these species, which are highly promising in therapeutics as antioxidant and anti-tumor agents. In this sense, the application of machine learning technology to model and optimize the production of phytochemicals is of extraordinary interest as it could favor their large-scale biotechnological exploitation in the cosmetic, food, and pharmaceutical industries.</p><p>In our opinion, the current trends and future challenges on the research of non-well characterized medicinal plants are: (i) the combination of plant in vitro systems, using molecular approaches, and nutritional studies [<xref rid="B128-pharmaceuticals-13-00444" ref-type="bibr">128</xref>], with the purpose of characterizing their full biosynthetic potential; (ii) the enhancement of secondary metabolism throughout the application of metabolic engineering, as it has been performed in the cases of <italic>trans</italic>-resveratrol [<xref rid="B168-pharmaceuticals-13-00444" ref-type="bibr">168</xref>] and terpenoid indole alkaloids [<xref rid="B169-pharmaceuticals-13-00444" ref-type="bibr">169</xref>]; (iii) the application of high throughput technologies, such as metabolomics, for the characterization of metabolic fingerprinting associated to elicitation of PSCCs, in response to plant stress, at a biochemical and biosynthetic level [<xref rid="B170-pharmaceuticals-13-00444" ref-type="bibr">170</xref>,<xref rid="B171-pharmaceuticals-13-00444" ref-type="bibr">171</xref>]. Finally, the combination of PTC and ML with omics technologies will assist to the establishment of new perspectives on the field of phytochemistry and the study of the biosynthetic potential of unexplored plants, as it is the case of <italic>Bryophyllum</italic>. Nowadays, the cornerstone in clinical management includes two easy concepts that are dietary modification associated with improvement of physical activity, also defined as lifestyle change [<xref rid="B172-pharmaceuticals-13-00444" ref-type="bibr">172</xref>,<xref rid="B173-pharmaceuticals-13-00444" ref-type="bibr">173</xref>] through a revaluation to popular medicine.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, P.G.-P. and E.L.-M.; funding acquisition, P.P.G.; investigation: P.G.-P. and E.L.-M.; methodology, M.L.; visualization: P.G.-P. and P.P.G.; writing&#x02014;original draft preparation, P.G.-P. and E.L.-M.; writing&#x02014;review and editing, M.L. and P.P.G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by Xunta de Galicia through &#x0201c;Red de Uso Sostenible de los Recursos Naturales y Agroalimentarios&#x0201d; (REDUSO, grant number ED431D 2017/18) and &#x0201c;Cluster of Agricultural Research and Development&#x0201d; (CITACA Strategic Partnership, gran numbered ED431E 2018/07). The authors acknowledge the FPU grant awarded to Pascual Garc&#x000ed;a-P&#x000e9;rez from the Spanish Ministry of Education (grant number FPU15/04849).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceuticals-13-00444"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adanson</surname><given-names>M.</given-names></name></person-group><source>Familles des Plantes par M. Adanson</source><publisher-name>chez Vincent</publisher-name><publisher-loc>Paris, France</publisher-loc><year>1763</year></element-citation></ref><ref id="B2-pharmaceuticals-13-00444"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akulova-Barlow</surname><given-names>Z.</given-names></name></person-group><article-title>Kalanchoe</article-title><source>Cactus Succul. J.</source><year>2009</year><volume>81</volume><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.2985/015.081.0601</pub-id></element-citation></ref><ref id="B3-pharmaceuticals-13-00444"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>G.</given-names></name><name><surname>Volmer</surname><given-names>P.A.</given-names></name></person-group><article-title>Kalanchoe species poisoning in pets</article-title><source>Vet. Med.</source><year>2004</year><volume>99</volume><fpage>933</fpage><lpage>936</lpage></element-citation></ref><ref id="B4-pharmaceuticals-13-00444"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Descoings</surname><given-names>B.</given-names></name></person-group><article-title>Le genre Kalanchoe structure et d&#x000e9;finition par Bernard Descoings</article-title><source>Le J. Bot.</source><year>2006</year><volume>33</volume><fpage>3</fpage><lpage>28</lpage></element-citation></ref><ref id="B5-pharmaceuticals-13-00444"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salisbury</surname><given-names>R.A.</given-names></name></person-group><article-title>Crassulaceae <italic>Bryophyllum</italic> salisb</article-title><source>Parad. Londinensis</source><year>1805</year><volume>1</volume><fpage>3</fpage></element-citation></ref><ref id="B6-pharmaceuticals-13-00444"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>J.G.</given-names></name></person-group><article-title>Notes on a Collection of Flowering Plants made by L. Kitching, Esq., in Madagascar in 1879</article-title><source>Bot. J. Linn. Soc.</source><year>1881</year><volume>18</volume><fpage>264</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1111/j.1095-8339.1881.tb01257.x</pub-id></element-citation></ref><ref id="B7-pharmaceuticals-13-00444"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernetskyy</surname><given-names>M.A.</given-names></name></person-group><article-title>The role of morpho-anatomical traits of the leaves in the taxonomy of Kalanchoideae Berg. subfamily (Crassulaceae DC.)</article-title><source>Mod. Phytomorphology</source><year>2012</year><volume>1</volume><fpage>15</fpage><lpage>18</lpage></element-citation></ref><ref id="B8-pharmaceuticals-13-00444"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehrig</surname><given-names>H.H.</given-names></name><name><surname>R&#x000f6;sicke</surname><given-names>H.</given-names></name><name><surname>Kluge</surname><given-names>M.</given-names></name></person-group><article-title>Detection of DNA polymorphisms in the genus Kalanchoe by RAPD-PCR fingerprint and its relationships to infrageneric taxonomic position and ecophysiological photosynthetic behaviour of the species</article-title><source>Plant Sci.</source><year>1997</year><volume>125</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/S0168-9452(97)04622-0</pub-id></element-citation></ref><ref id="B9-pharmaceuticals-13-00444"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamburger</surname><given-names>M.</given-names></name><name><surname>Potterat</surname><given-names>O.</given-names></name><name><surname>F&#x000fc;rer</surname><given-names>K.</given-names></name><name><surname>Sim&#x000f5;es-W&#x000fc;st</surname><given-names>A.P.</given-names></name><name><surname>Von Mandach</surname><given-names>U.</given-names></name></person-group><article-title><italic>Bryophyllum</italic> pinnatum - Reverse engineering of an anthroposophic herbal medicine</article-title><source>Nat. Prod. Commun.</source><year>2017</year><volume>12</volume><fpage>1359</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1177/1934578X1701200847</pub-id></element-citation></ref><ref id="B10-pharmaceuticals-13-00444"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushman</surname><given-names>J.C.</given-names></name></person-group><article-title>Crassulacean acid metabolism: Recent advances and future opportunities</article-title><source>Funct. Plant Biol.</source><year>2005</year><volume>32</volume><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1071/FP05111</pub-id><pub-id pub-id-type="pmid">32689139</pub-id></element-citation></ref><ref id="B11-pharmaceuticals-13-00444"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ea;s</surname><given-names>H.M.P.</given-names></name><name><surname>Koenig</surname><given-names>D.</given-names></name><name><surname>Townsley</surname><given-names>B.T.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Sinha</surname><given-names>N.R.</given-names></name></person-group><article-title>Truncation of LEAFY COTYLEDON1 protein is required for asexual reproduction in Kalancho&#x000eb; daigremontiana</article-title><source>Plant Physiol.</source><year>2014</year><volume>165</volume><fpage>196</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1104/pp.114.237222</pub-id><pub-id pub-id-type="pmid">24664206</pub-id></element-citation></ref><ref id="B12-pharmaceuticals-13-00444"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ea;s</surname><given-names>H.</given-names></name><name><surname>Sinha</surname><given-names>N.</given-names></name></person-group><article-title>The &#x0201c;Mother of Thousands&#x0201d; (Kalancho&#x000eb; daigremontiana): A plant model for asexual reproduction and CAM studies</article-title><source>Cold Spring Harb. Protoc.</source><year>2009</year><volume>4</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="B13-pharmaceuticals-13-00444"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Barreal</surname><given-names>M.E.</given-names></name><name><surname>Rojo-De Dios</surname><given-names>L.</given-names></name><name><surname>Cameselle-Teijeiro</surname><given-names>J.F.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Bioactive natural products from the genus Kalanchoe as cancer chemopreventive agents: A review</article-title><source>Studies in Natural Products Chemistry</source><person-group person-group-type="editor"><name><surname>Rahman</surname><given-names>A.</given-names></name></person-group><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2018</year><volume>Volume 61</volume><fpage>49</fpage><lpage>84</lpage><isbn>9780444641830</isbn></element-citation></ref><ref id="B14-pharmaceuticals-13-00444"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boxall</surname><given-names>S.F.</given-names></name><name><surname>Kadu</surname><given-names>N.</given-names></name><name><surname>Dever</surname><given-names>L.V.</given-names></name><name><surname>Knerov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Waller</surname><given-names>J.L.</given-names></name><name><surname>Gould</surname><given-names>P.J.D.</given-names></name><name><surname>Hartwell</surname><given-names>J.</given-names></name></person-group><article-title>Kalancho&#x000eb; PPC1 is essential for crassulacean acid metabolism and the regulation of core circadian clock and guard cell signaling genes</article-title><source>Plant Cell</source><year>2020</year><volume>32</volume><fpage>1136</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1105/tpc.19.00481</pub-id><?supplied-pmid 32051209?><pub-id pub-id-type="pmid">32051209</pub-id></element-citation></ref><ref id="B15-pharmaceuticals-13-00444"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehrig</surname><given-names>H.</given-names></name><name><surname>Gau&#x000df;mann</surname><given-names>O.</given-names></name><name><surname>Marx</surname><given-names>H.</given-names></name><name><surname>Schwarzott</surname><given-names>D.</given-names></name><name><surname>Kluge</surname><given-names>M.</given-names></name></person-group><article-title>Molecular phylogeny of the genus Kalanchoe (Crassulaceae) inferred from nucleotide sequences of the ITS-1 and ITS-2 regions</article-title><source>Plant Sci.</source><year>2001</year><volume>160</volume><fpage>827</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1016/S0168-9452(00)00447-7</pub-id><pub-id pub-id-type="pmid">11297779</pub-id></element-citation></ref><ref id="B16-pharmaceuticals-13-00444"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulka</surname><given-names>R.G.</given-names></name></person-group><article-title>Cytokinins inhibit epiphyllous plantlet development on leaves of <italic>Bryophyllum</italic> (Kalancho&#x000eb;) marnierianum</article-title><source>J. Exp. Bot.</source><year>2006</year><volume>57</volume><fpage>4089</fpage><lpage>4098</lpage><pub-id pub-id-type="doi">10.1093/jxb/erl180</pub-id><pub-id pub-id-type="pmid">17077184</pub-id></element-citation></ref><ref id="B17-pharmaceuticals-13-00444"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ea;s</surname><given-names>H.M.P.</given-names></name><name><surname>Champagne</surname><given-names>C.E.M.</given-names></name><name><surname>Townsley</surname><given-names>B.T.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Malh&#x000f3;</surname><given-names>R.</given-names></name><name><surname>Pedroso</surname><given-names>M.C.</given-names></name><name><surname>Harada</surname><given-names>J.J.</given-names></name><name><surname>Sinha</surname><given-names>N.R.</given-names></name></person-group><article-title>Evolution of asexual reproduction in leaves of the genus Kalancho&#x000eb;</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>15578</fpage><lpage>15583</lpage><pub-id pub-id-type="pmid">17893341</pub-id></element-citation></ref><ref id="B18-pharmaceuticals-13-00444"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>B.K.</given-names></name></person-group><article-title>Daigremontiana as a Model Plant for the Study of Auxin Effects in Plant Morphology</article-title><source>J. Plant Biochem. Physiol.</source><year>2014</year><volume>02</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.4172/2329-9029.1000e120</pub-id></element-citation></ref><ref id="B19-pharmaceuticals-13-00444"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasternak</surname><given-names>T.</given-names></name><name><surname>Dudits</surname><given-names>D.</given-names></name></person-group><article-title>Epigenetic clues to better understanding of the asexual embryogenesis In planta and In vitro</article-title><source>Front. Plant Sci.</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.3389/fpls.2019.00778</pub-id><pub-id pub-id-type="pmid">30723482</pub-id></element-citation></ref><ref id="B20-pharmaceuticals-13-00444"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>T.</given-names></name><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name></person-group><article-title>Analysis of gene expression in <italic><italic>Kalanchoe daigremontiana</italic></italic> leaves during plantlet formation under drought stress</article-title><source>Electron. J. Biotechnol.</source><year>2013</year><volume>16</volume></element-citation></ref><ref id="B21-pharmaceuticals-13-00444"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulka</surname><given-names>R.G.</given-names></name></person-group><article-title>Hormonal control of root development on epiphyllous plantlets of <italic>Bryophyllum</italic> (Kalancho&#x000eb;) marnierianum: Role of auxin and ethylene</article-title><source>J. Exp. Bot.</source><year>2008</year><volume>59</volume><fpage>2361</fpage><lpage>2370</lpage><pub-id pub-id-type="doi">10.1093/jxb/ern106</pub-id><pub-id pub-id-type="pmid">18544609</pub-id></element-citation></ref><ref id="B22-pharmaceuticals-13-00444"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>I.</given-names></name><name><surname>Nassar</surname><given-names>J.M.</given-names></name></person-group><article-title>Reproductive and recruitment traits as indicators of the invasive potential of <italic>Kalanchoe daigremontiana</italic> (Crassulaceae) and Stapelia gigantea (Apocynaceae) in a Neotropical arid zone</article-title><source>J. Arid Environ.</source><year>2009</year><volume>73</volume><fpage>978</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.1016/j.jaridenv.2009.05.004</pub-id></element-citation></ref><ref id="B23-pharmaceuticals-13-00444"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrando-Moraira</surname><given-names>S.</given-names></name><name><surname>Vitales</surname><given-names>D.</given-names></name><name><surname>Nualart</surname><given-names>N.</given-names></name><name><surname>G&#x000f3;mez-Bellver</surname><given-names>C.</given-names></name><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>N.</given-names></name><name><surname>Mass&#x000f3;</surname><given-names>S.</given-names></name><name><surname>Cach&#x000f3;n-Ferrero</surname><given-names>P.</given-names></name><name><surname>Gonz&#x000e1;lez-Guti&#x000e9;rrez</surname><given-names>P.A.</given-names></name><name><surname>Guillot</surname><given-names>D.</given-names></name><name><surname>Herrera</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Global distribution patterns and niche modelling of the invasive Kalanchoe &#x000d7; houghtonii (Crassulaceae)</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>3143</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-60079-2</pub-id><pub-id pub-id-type="pmid">32081991</pub-id></element-citation></ref><ref id="B24-pharmaceuticals-13-00444"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziejczyk-Czepas</surname><given-names>J.</given-names></name><name><surname>Nowak</surname><given-names>P.</given-names></name><name><surname>Wachowicz</surname><given-names>B.</given-names></name><name><surname>Piechocka</surname><given-names>J.</given-names></name><name><surname>G&#x00142;owacki</surname><given-names>R.</given-names></name><name><surname>Moniuszko-Szajwaj</surname><given-names>B.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant efficacy of <italic>Kalanchoe daigremontiana</italic> bufadienolide-rich fraction in blood plasma in vitro</article-title><source>Pharm. Biol.</source><year>2016</year><volume>54</volume><fpage>3182</fpage><lpage>3188</lpage><pub-id pub-id-type="doi">10.1080/13880209.2016.1214740</pub-id><?supplied-pmid 27488985?><pub-id pub-id-type="pmid">27488985</pub-id></element-citation></ref><ref id="B25-pharmaceuticals-13-00444"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojewole</surname><given-names>J.A.O.</given-names></name></person-group><article-title>Antinociceptive, anti-inflammatory and antidiabetic effects of <italic>Bryophyllum pinnatum</italic> (Crassulaceae) leaf aqueous extract</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>99</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.01.025</pub-id><?supplied-pmid 15848014?><pub-id pub-id-type="pmid">15848014</pub-id></element-citation></ref><ref id="B26-pharmaceuticals-13-00444"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamboj</surname><given-names>A.</given-names></name><name><surname>Saluja</surname><given-names>A.K.</given-names></name></person-group><article-title><italic>Bryophyllum pinnatum</italic> (Lam.) Kurz.: Phytochemical and pharmacological profile: A review</article-title><source>Pharmacogn. Rev.</source><year>2009</year><volume>3</volume><fpage>364</fpage><lpage>374</lpage></element-citation></ref><ref id="B27-pharmaceuticals-13-00444"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinpelu</surname><given-names>D.A.</given-names></name></person-group><article-title>Antimicrobial activity of <italic>Bryophyllum pinnatum</italic> leaves</article-title><source>Fitoterapia</source><year>2000</year><volume>71</volume><fpage>193</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(99)00135-5</pub-id><pub-id pub-id-type="pmid">10727819</pub-id></element-citation></ref><ref id="B28-pharmaceuticals-13-00444"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mawla</surname><given-names>F.</given-names></name><name><surname>Khatoon</surname><given-names>S.</given-names></name><name><surname>Rehana</surname><given-names>F.</given-names></name><name><surname>Jahan</surname><given-names>S.</given-names></name><name><surname>Moshiur</surname><given-names>M.R.</given-names></name><name><surname>Hossain</surname><given-names>S.</given-names></name><name><surname>Haq</surname><given-names>W.M.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name><name><surname>Debnath</surname><given-names>K.</given-names></name><name><surname>Rahmatullah</surname><given-names>M.</given-names></name></person-group><article-title>Ethnomedicinal plants of folk medicinal practitioners in four villages of natore and rajshahi districts, bangladesh</article-title><source>Am. J. Sustain. Agric.</source><year>2012</year><volume>6</volume><fpage>406</fpage><lpage>416</lpage></element-citation></ref><ref id="B29-pharmaceuticals-13-00444"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>Y.J.</given-names></name><name><surname>Yang</surname><given-names>M.Y.</given-names></name><name><surname>Leu</surname><given-names>Y.L.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Wan</surname><given-names>C.F.</given-names></name><name><surname>Chang</surname><given-names>M.Y.</given-names></name><name><surname>Chang</surname><given-names>C.J.</given-names></name></person-group><article-title>Kalanchoe tubiflora extract inhibits cell proliferation by affecting the mitotic apparatus</article-title><source>BMC Complement. Altern. Med.</source><year>2012</year><volume>12</volume><pub-id pub-id-type="doi">10.1186/1472-6882-12-149</pub-id></element-citation></ref><ref id="B30-pharmaceuticals-13-00444"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abebe</surname><given-names>W.</given-names></name></person-group><article-title>An Overview of Ethiopian Traditional Medicinal Plants Used for Cancer Treatment</article-title><source>European J. Med. Plants</source><year>2016</year><volume>14</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.9734/EJMP/2016/25670</pub-id></element-citation></ref><ref id="B31-pharmaceuticals-13-00444"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supratman</surname><given-names>U.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Akiyama</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name><name><surname>Murakami</surname><given-names>A.</given-names></name><name><surname>Sakai</surname><given-names>H.</given-names></name><name><surname>Koshimizu</surname><given-names>K.</given-names></name><name><surname>Ohigashi</surname><given-names>H.</given-names></name></person-group><article-title>Anti-tumor promoting activity of bufadienolides from <italic>Kalanchoe pinnata</italic> and <italic>K. daigremontiana</italic> &#x000d7; tubiflora</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2001</year><volume>65</volume><fpage>947</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1271/bbb.65.947</pub-id><pub-id pub-id-type="pmid">11388478</pub-id></element-citation></ref><ref id="B32-pharmaceuticals-13-00444"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguelefack</surname><given-names>T.B.</given-names></name><name><surname>Nana</surname><given-names>P.</given-names></name><name><surname>Atsamo</surname><given-names>A.D.</given-names></name><name><surname>Dimo</surname><given-names>T.</given-names></name><name><surname>Watcho</surname><given-names>P.</given-names></name><name><surname>Dongmo</surname><given-names>A.B.</given-names></name><name><surname>Tapondjou</surname><given-names>L.A.</given-names></name><name><surname>Njamen</surname><given-names>D.</given-names></name><name><surname>Wansi</surname><given-names>S.L.</given-names></name><name><surname>Kamanyi</surname><given-names>A.</given-names></name></person-group><article-title>Analgesic and anticonvulsant effects of extracts from the leaves of <italic>Kalanchoe crenata</italic> (Andrews) Haworth (Crassulaceae)</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>106</volume><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.12.003</pub-id><pub-id pub-id-type="pmid">16423479</pub-id></element-citation></ref><ref id="B33-pharmaceuticals-13-00444"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamgang</surname><given-names>R.</given-names></name><name><surname>Youmbi Mboumi</surname><given-names>R.</given-names></name><name><surname>Foyet Fondjo</surname><given-names>A.</given-names></name><name><surname>Fokam Tagne</surname><given-names>M.A.</given-names></name><name><surname>Mengue N&#x02019;dill&#x000e9;</surname><given-names>G.P.R.</given-names></name><name><surname>Ngogang Yonkeu</surname><given-names>J.</given-names></name></person-group><article-title>Antihyperglycaemic potential of the water-ethanol extract of Kalanchoe crenata (Crassulaceae)</article-title><source>J. Nat. Med.</source><year>2008</year><volume>62</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1007/s11418-007-0179-y</pub-id><?supplied-pmid 18404339?><pub-id pub-id-type="pmid">18404339</pub-id></element-citation></ref><ref id="B34-pharmaceuticals-13-00444"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinsulire</surname><given-names>O.R.</given-names></name><name><surname>Aibinu</surname><given-names>I.E.</given-names></name><name><surname>Adenipekun</surname><given-names>T.</given-names></name><name><surname>Adelowotan</surname><given-names>T.</given-names></name><name><surname>Odugbemi</surname><given-names>T.</given-names></name></person-group><article-title>In vitro antimicrobial activity of crude extracts from plants <italic>Bryophyllum pinnatum</italic> and <italic>Kalanchoe crenata</italic></article-title><source>African J. Tradit. Complement. Altern. Med.</source><year>2007</year><volume>4</volume><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v4i3.31227</pub-id></element-citation></ref><ref id="B35-pharmaceuticals-13-00444"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malan</surname><given-names>D.F.</given-names></name><name><surname>Neuba</surname><given-names>D.F.R.</given-names></name></person-group><article-title>Traditional practices and medicinal plants use during pregnancy by Anyi-Ndenye women (Eastern C&#x000f4;te d&#x02019;Ivoire)</article-title><source>Afr. J. Reprod. Health</source><year>2011</year><volume>15</volume><fpage>85</fpage><lpage>93</lpage><?supplied-pmid 21987942?><pub-id pub-id-type="pmid">21987942</pub-id></element-citation></ref><ref id="B36-pharmaceuticals-13-00444"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000fc;sskind</surname><given-names>M.</given-names></name><name><surname>Th&#x000fc;rmann</surname><given-names>P.A.</given-names></name><name><surname>L&#x000fc;ke</surname><given-names>C.</given-names></name><name><surname>Jeschke</surname><given-names>E.</given-names></name><name><surname>Tabali</surname><given-names>M.</given-names></name><name><surname>Matthes</surname><given-names>H.</given-names></name><name><surname>Ostermann</surname><given-names>T.</given-names></name></person-group><article-title>Adverse drug reactions in a complementary medicine hospital: A prospective, intensified surveillance study</article-title><source>Evidence-based Complement. Altern. Med.</source><year>2012</year><volume>2012</volume><pub-id pub-id-type="doi">10.1155/2012/320760</pub-id><?supplied-pmid 22315630?><pub-id pub-id-type="pmid">22315630</pub-id></element-citation></ref><ref id="B37-pharmaceuticals-13-00444"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richwagen</surname><given-names>N.</given-names></name><name><surname>Lyles</surname><given-names>J.T.</given-names></name><name><surname>Dale</surname><given-names>B.L.F.</given-names></name><name><surname>Quave</surname><given-names>C.L.</given-names></name></person-group><article-title>Antibacterial activity of Kalanchoe mortagei and K. fedtschenkoi against ESKAPE pathogens</article-title><source>Front. Pharmacol.</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.3389/fphar.2019.00067</pub-id><?supplied-pmid 30792655?><pub-id pub-id-type="pmid">30728774</pub-id></element-citation></ref><ref id="B38-pharmaceuticals-13-00444"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cumberbatch</surname><given-names>A.</given-names></name></person-group><article-title>An Ethonobotanical Survey of Medicinal Plant Usage in Salvador de Bahia, Brazil</article-title><source>CGI Gr.</source><year>2011</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://radar.auctr.edu/islandora/object/sc.gstem%3A2011_cumberbatch_ashli">https://radar.auctr.edu/islandora/object/sc.gstem%3A2011_cumberbatch_ashli</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-10-21">(accessed on 21 October 2020)</date-in-citation></element-citation></ref><ref id="B39-pharmaceuticals-13-00444"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>S.S.</given-names></name><name><surname>Muzitano</surname><given-names>M.F.</given-names></name><name><surname>Camargo</surname><given-names>L.M.M.</given-names></name><name><surname>Coutinho</surname><given-names>M.A.S.</given-names></name></person-group><article-title>Therapeutic potential of Kalanchoe species: Flavonoids and other secondary metabolites</article-title><source>Nat. Prod. Commun.</source><year>2008</year><volume>3</volume><fpage>2151</fpage><lpage>2164</lpage><pub-id pub-id-type="doi">10.1177/1934578X0800301236</pub-id></element-citation></ref><ref id="B40-pharmaceuticals-13-00444"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su&#x000e1;rez</surname><given-names>F.S.</given-names></name><name><surname>Ramirez</surname><given-names>A.M.</given-names></name><name><surname>L&#x000f3;pez-Marure</surname><given-names>R.</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>R.M.P.</given-names></name></person-group><article-title>In vitro cytotoxic potential and apoptotic activity of bufadienolide-rich fraction from leaves of Kalanchoe mortagei against human HeLa cancer cells</article-title><source>Int. J. Ayurvedic Med.</source><year>2018</year><volume>9</volume><fpage>25</fpage><lpage>33</lpage></element-citation></ref><ref id="B41-pharmaceuticals-13-00444"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera-Marin</surname><given-names>B.</given-names></name><name><surname>S&#x000e1;nchez-S&#x000e1;en</surname><given-names>M.</given-names></name></person-group><article-title>Plantas medicinales y predictibilidad de uso en algunas veredas del corregimiento de San Crist&#x000f3;bal (Antioquia), Colombia</article-title><source>Actual. Biol&#x000f3;gicas</source><year>2016</year><volume>38</volume><fpage>167</fpage><lpage>180</lpage></element-citation></ref><ref id="B42-pharmaceuticals-13-00444"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herawati</surname><given-names>M.H.</given-names></name><name><surname>Husin</surname><given-names>N.</given-names></name></person-group><article-title>Berbagai jenis tumbuhan yang berkhasiat sebagai obat kecacingan</article-title><source>Media Penelit. dan Pengemb. Kesehat.</source><year>2000</year><volume>10</volume><comment>Available online: <ext-link ext-link-type="uri" xlink:href="isis://www.neliti.com/publications/158068/berbagai-jenis-tumbuhan-yang-berkhasiat-sebagai-obat-kecacingan">isis://www.neliti.com/publications/158068/berbagai-jenis-tumbuhan-yang-berkhasiat-sebagai-obat-kecacingan</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-10-21">(accessed on 21 October 2020)</date-in-citation></element-citation></ref><ref id="B43-pharmaceuticals-13-00444"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajsekhar</surname><given-names>P.B.</given-names></name><name><surname>Arvind Bharani</surname><given-names>R.S.</given-names></name><name><surname>Ramachandran</surname><given-names>M.</given-names></name><name><surname>Jini Angel</surname><given-names>K.</given-names></name><name><surname>Rajsekhar</surname><given-names>S.P.V.</given-names></name></person-group><article-title>The &#x0201c;wonder plant&#x0201d; Kalanchoe pinnata (linn.) pers.: A review</article-title><source>J. Appl. Pharm. Sci.</source><year>2016</year><volume>6</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.7324/JAPS.2016.60326</pub-id></element-citation></ref><ref id="B44-pharmaceuticals-13-00444"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmatullah</surname><given-names>M.</given-names></name><name><surname>Mollik</surname><given-names>M.A.H.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Abbas</surname><given-names>M.F.B.</given-names></name><name><surname>Jahan</surname><given-names>R.</given-names></name><name><surname>Khatun</surname><given-names>A.</given-names></name><name><surname>Seraj</surname><given-names>S.</given-names></name><name><surname>Ahsan</surname><given-names>S.</given-names></name></person-group><article-title>An ethnomedicinal survey of vitbilia village in sujanagar sub-district of pabna district, Bangladesh</article-title><source>Am. J. Sustain. Agric.</source><year>2010</year><volume>4</volume><fpage>302</fpage><lpage>308</lpage></element-citation></ref><ref id="B45-pharmaceuticals-13-00444"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lans</surname><given-names>C.A.</given-names></name></person-group><article-title>Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus</article-title><source>J. Ethnobiol. Ethnomed.</source><year>2006</year><volume>2</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/1746-4269-2-45</pub-id><?supplied-pmid 17040567?><pub-id pub-id-type="pmid">16393342</pub-id></element-citation></ref><ref id="B46-pharmaceuticals-13-00444"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhowmik</surname><given-names>R.</given-names></name><name><surname>Saha</surname><given-names>M.R.</given-names></name><name><surname>Rahman</surname><given-names>M.A.</given-names></name><name><surname>Islam</surname><given-names>M.A.U.</given-names></name></person-group><article-title>Ethnomedicinal Survey of Plants in the Southern District Noakhali, Bangladesh</article-title><source>Bangladesh Pharm. J.</source><year>2015</year><volume>17</volume><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.3329/bpj.v17i2.22342</pub-id></element-citation></ref><ref id="B47-pharmaceuticals-13-00444"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>J.M.</given-names></name><name><surname>Cunha</surname><given-names>L.M.</given-names></name><name><surname>Azevedo</surname><given-names>E.P.</given-names></name><name><surname>Louren&#x000e7;o</surname><given-names>E.M.G.</given-names></name><name><surname>Fernandes-Pedrosa</surname><given-names>M.F.</given-names></name><name><surname>Zucolotto</surname><given-names>S.M.</given-names></name></person-group><article-title>Kalanchoe laciniata and <italic>Bryophyllum pinnatum</italic>: An updated review about ethnopharmacology, phytochemistry, pharmacology and toxicology</article-title><source>Rev. Bras. Farmacogn.</source><year>2019</year><volume>29</volume><fpage>529</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2019.01.012</pub-id></element-citation></ref><ref id="B48-pharmaceuticals-13-00444"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>P.</given-names></name><name><surname>Dollo</surname><given-names>M.</given-names></name><name><surname>Choudhury</surname><given-names>M.D.</given-names></name><name><surname>Choudhury</surname><given-names>D.</given-names></name></person-group><article-title>Documentation of traditional herbal knowledge of Khamptis of Arunachal Pradesh</article-title><source>Indian J. Tradit. Knowl.</source><year>2008</year><volume>7</volume><fpage>438</fpage><lpage>442</lpage></element-citation></ref><ref id="B49-pharmaceuticals-13-00444"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M.A.</given-names></name><name><surname>Islam</surname><given-names>M.K.</given-names></name><name><surname>Siraj</surname><given-names>M.A.</given-names></name><name><surname>Saha</surname><given-names>S.</given-names></name><name><surname>Barman</surname><given-names>A.K.</given-names></name><name><surname>Awang</surname><given-names>K.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Shilpi</surname><given-names>J.A.</given-names></name><name><surname>Jahan</surname><given-names>R.</given-names></name><name><surname>Islam</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Ethnomedicinal survey of various communities residing in Garo Hills of Durgapur, Bangladesh</article-title><source>J. Ethnobiol. Ethnomed.</source><year>2015</year><volume>11</volume><pub-id pub-id-type="doi">10.1186/s13002-015-0033-3</pub-id></element-citation></ref><ref id="B50-pharmaceuticals-13-00444"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okwu</surname><given-names>D.E.</given-names></name><name><surname>Nnamdi</surname><given-names>F.U.</given-names></name></person-group><article-title>Two novel flavonoids from <italic>Bryophyllum pinnatum</italic> and their antimicrobial activity</article-title><source>J. Chem. Pharm. Res.</source><year>2011</year><volume>3</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="B51-pharmaceuticals-13-00444"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budi</surname><given-names>V.</given-names></name><name><surname>Sihotang</surname><given-names>L.</given-names></name></person-group><article-title>Ethnomedicinal study of the Sundanese people at the Bodogol area, Gede Pangrango Mountain National Park, West Java</article-title><source>Gard. Bull. Singapore</source><year>2011</year><volume>63</volume><fpage>527</fpage><lpage>534</lpage></element-citation></ref><ref id="B52-pharmaceuticals-13-00444"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namukobe</surname><given-names>J.</given-names></name><name><surname>Kasenene</surname><given-names>J.M.</given-names></name><name><surname>Kiremire</surname><given-names>B.T.</given-names></name><name><surname>Byamukama</surname><given-names>R.</given-names></name><name><surname>Kamatenesi-Mugisha</surname><given-names>M.</given-names></name><name><surname>Krief</surname><given-names>S.</given-names></name><name><surname>Dumontet</surname><given-names>V.</given-names></name><name><surname>Kabasa</surname><given-names>J.D.</given-names></name></person-group><article-title>Traditional plants used for medicinal purposes by local communities around the Northern sector of Kibale National Park, Uganda</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>136</volume><fpage>236</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.04.044</pub-id><pub-id pub-id-type="pmid">21550390</pub-id></element-citation></ref><ref id="B53-pharmaceuticals-13-00444"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>Z.R.</given-names></name><name><surname>Peng</surname><given-names>W.H.</given-names></name><name><surname>Ho</surname><given-names>Y.L.</given-names></name><name><surname>Huang</surname><given-names>S.C.</given-names></name><name><surname>Huang</surname><given-names>T.H.</given-names></name><name><surname>Lai</surname><given-names>S.C.</given-names></name><name><surname>Ku</surname><given-names>Y.R.</given-names></name><name><surname>Tsai</surname><given-names>J.C.</given-names></name><name><surname>Wang</surname><given-names>C.Y.</given-names></name><name><surname>Chang</surname><given-names>Y.S.</given-names></name></person-group><article-title>Analgesic and anti-inflammatory activities of the methanol extract of <italic>Kalanchoe gracilis</italic> (L.) DC stem in mice</article-title><source>Am. J. Chin. Med.</source><year>2010</year><volume>38</volume><fpage>529</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1142/S0192415X10008032</pub-id><?supplied-pmid 20503470?><pub-id pub-id-type="pmid">20503470</pub-id></element-citation></ref><ref id="B54-pharmaceuticals-13-00444"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.Y.</given-names></name><name><surname>Huang</surname><given-names>S.C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Lai</surname><given-names>Z.R.</given-names></name><name><surname>Kung</surname><given-names>S.H.</given-names></name><name><surname>Chang</surname><given-names>Y.S.</given-names></name><name><surname>Lin</surname><given-names>C.W.</given-names></name></person-group><article-title>Antiviral ability of <italic>Kalanchoe gracilis</italic> leaf extract against Enterovirus 71 and coxsackievirus A16</article-title><source>Evidence-based Complement. Altern. Med.</source><year>2012</year><volume>2012</volume><fpage>503165</fpage></element-citation></ref><ref id="B55-pharmaceuticals-13-00444"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milad</surname><given-names>R.</given-names></name></person-group><article-title>Genus Kalanchoe (Crassulaceae): A review of its ethnomedicinal, botanical, chemical and pharmacological properties</article-title><source>European J. Med. Plants</source><year>2014</year><volume>4</volume><fpage>86</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.9734/EJMP/2014/5901</pub-id></element-citation></ref><ref id="B56-pharmaceuticals-13-00444"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Snafi</surname><given-names>A.</given-names></name></person-group><article-title>The chemical constituents and pharmacological effects of <italic>Bryophyllum</italic> calycinum. A review</article-title><source>Int. J. Pharma Sci. Res.</source><year>2013</year><volume>4</volume><fpage>171</fpage><lpage>176</lpage></element-citation></ref><ref id="B57-pharmaceuticals-13-00444"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ara&#x000fa;jo</surname><given-names>E.R.D.</given-names></name><name><surname>F&#x000e9;lix-Silva</surname><given-names>J.</given-names></name><name><surname>Xavier-Santos</surname><given-names>J.B.</given-names></name><name><surname>Fernandes</surname><given-names>J.M.</given-names></name><name><surname>Guerra</surname><given-names>G.C.B.</given-names></name><name><surname>de Ara&#x000fa;jo</surname><given-names>A.A.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>D.F.d.S.</given-names></name><name><surname>de Santis Ferreira</surname><given-names>L.</given-names></name><name><surname>da Silva J&#x000fa;nior</surname><given-names>A.A.</given-names></name><name><surname>Fernandes-Pedrosa</surname><given-names>M.d.F.</given-names></name><etal/></person-group><article-title>Local anti-inflammatory activity: Topical formulation containing Kalanchoe brasiliensis and Kalanchoe pinnata leaf aqueous extract</article-title><source>Biomed. Pharmacother.</source><year>2019</year><volume>113</volume><fpage>108721</fpage><pub-id pub-id-type="pmid">30856538</pub-id></element-citation></ref><ref id="B58-pharmaceuticals-13-00444"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.C.</given-names></name><name><surname>Huang</surname><given-names>G.J.</given-names></name><name><surname>Liaw</surname><given-names>C.C.</given-names></name><name><surname>Yang</surname><given-names>C.S.</given-names></name><name><surname>Yang</surname><given-names>C.P.</given-names></name><name><surname>Kuo</surname><given-names>C.L.</given-names></name><name><surname>Tseng</surname><given-names>Y.H.</given-names></name><name><surname>Wang</surname><given-names>S.Y.</given-names></name><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name></person-group><article-title>A new megastigmane from Kalanchoe tubiflora (Harvey) Hamet</article-title><source>Phytochem. Lett.</source><year>2013</year><volume>6</volume><fpage>379</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2013.04.002</pub-id></element-citation></ref><ref id="B59-pharmaceuticals-13-00444"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anisimov</surname><given-names>M.M.</given-names></name><name><surname>Gerasimenko</surname><given-names>N.I.</given-names></name><name><surname>Chaikina</surname><given-names>E.L.</given-names></name><name><surname>Serebryakov</surname><given-names>Y.M.</given-names></name></person-group><article-title>Biological activity of metabolites of the herb <italic>Kalanchoe daigremontiana</italic> (Hamet de la Bathie) Jacobs et Perr</article-title><source>Biol. Bull.</source><year>2009</year><volume>36</volume><fpage>568</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1134/S1062359009060041</pub-id></element-citation></ref><ref id="B60-pharmaceuticals-13-00444"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000dc;rm&#x000e9;nyi</surname><given-names>F.G.G.</given-names></name><name><surname>Saraiva</surname><given-names>G.d.N.</given-names></name><name><surname>Casanova</surname><given-names>L.M.</given-names></name><name><surname>Matos</surname><given-names>A.d.S.</given-names></name><name><surname>de Magalh&#x000e3;es Camargo</surname><given-names>L.M.</given-names></name><name><surname>Romanos</surname><given-names>M.T.V.</given-names></name><name><surname>Costa</surname><given-names>S.S.</given-names></name></person-group><article-title>Anti-HSV-1 and HSV-2 Flavonoids and a New Kaempferol Triglycoside from the Medicinal Plant <italic>Kalanchoe daigremontiana</italic></article-title><source>Chem. Biodivers.</source><year>2016</year><volume>13</volume><fpage>1707</fpage><lpage>1714</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201600127</pub-id><pub-id pub-id-type="pmid">27472283</pub-id></element-citation></ref><ref id="B61-pharmaceuticals-13-00444"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahata</surname><given-names>S.</given-names></name><name><surname>Maru</surname><given-names>S.</given-names></name><name><surname>Shukla</surname><given-names>S.</given-names></name><name><surname>Pandey</surname><given-names>A.</given-names></name><name><surname>Mugesh</surname><given-names>G.</given-names></name><name><surname>Das</surname><given-names>B.C.</given-names></name><name><surname>Bharti</surname><given-names>A.C.</given-names></name></person-group><article-title>Anticancer property of <italic>Bryophyllum pinnata</italic> (Lam.) Oken. leaf on human cervical cancer cells</article-title><source>BMC Complement. Altern. Med.</source><year>2012</year><volume>12</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-12-15</pub-id><pub-id pub-id-type="pmid">22405256</pub-id></element-citation></ref><ref id="B62-pharmaceuticals-13-00444"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Lozano-Milo</surname><given-names>E.</given-names></name><name><surname>Land&#x000ed;n</surname><given-names>M.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Combining medicinal plant in vitro culture with machine learning technologies for maximizing the production of phenolic compounds</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>210</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9030210</pub-id></element-citation></ref><ref id="B63-pharmaceuticals-13-00444"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogucka-Kocka</surname><given-names>A.</given-names></name><name><surname>Zidorn</surname><given-names>C.</given-names></name><name><surname>Kasprzycka</surname><given-names>M.</given-names></name><name><surname>Szymczak</surname><given-names>G.</given-names></name><name><surname>Szewczyk</surname><given-names>K.</given-names></name></person-group><article-title>Phenolic acid content, antioxidant and cytotoxic activities of four Kalancho&#x000eb; species</article-title><source>Saudi J. Biol. Sci.</source><year>2016</year><volume>25</volume><fpage>622</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2016.01.037</pub-id><?supplied-pmid 29740226?><pub-id pub-id-type="pmid">29740226</pub-id></element-citation></ref><ref id="B64-pharmaceuticals-13-00444"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Losada-Barreiro</surname><given-names>S.</given-names></name><name><surname>Bravo-D&#x000ed;az</surname><given-names>C.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Exploring the use of <italic>Bryophyllum</italic> as natural source of bioactive compounds with antioxidant activity to prevent lipid oxidation of fish oil-in-water emulsions</article-title><source>Plants</source><year>2020</year><volume>9</volume><elocation-id>1012</elocation-id><pub-id pub-id-type="doi">10.3390/plants9081012</pub-id><?supplied-pmid 32796522?><pub-id pub-id-type="pmid">32796522</pub-id></element-citation></ref><ref id="B65-pharmaceuticals-13-00444"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maharani</surname><given-names>R.</given-names></name><name><surname>Fajriah</surname><given-names>S.</given-names></name><name><surname>Hardiawan</surname><given-names>R.</given-names></name><name><surname>Supratman</surname><given-names>U.</given-names></name></person-group><article-title>Insecticidal bufadienolides from the leaves of <italic>Kalanchoe daigremontiana</italic> (Crassulaceae)</article-title><source>Proceeding Int. Semin. Chem.</source><year>2008</year><volume>11</volume><fpage>236</fpage><lpage>239</lpage></element-citation></ref><ref id="B66-pharmaceuticals-13-00444"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supratman</surname><given-names>U.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Akiyama</surname><given-names>K.</given-names></name><name><surname>Hayash</surname><given-names>H.</given-names></name></person-group><article-title>New insecticidal bufadienolide, bryophyllin C, from <italic>Kalanchoe pinnata</italic></article-title><source>Biosci. Biotechnol. Biochem.</source><year>2000</year><volume>64</volume><fpage>1310</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1271/bbb.64.1310</pub-id><pub-id pub-id-type="pmid">10923811</pub-id></element-citation></ref><ref id="B67-pharmaceuticals-13-00444"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supratman</surname><given-names>U.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Akiyama</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name></person-group><article-title>Insecticidal compounds from <italic>Kalanchoe daigremontiana</italic> x tubiflora</article-title><source>Phytochemistry</source><year>2001</year><volume>58</volume><fpage>311</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(01)00199-6</pub-id><pub-id pub-id-type="pmid">11551556</pub-id></element-citation></ref><ref id="B68-pharmaceuticals-13-00444"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziejczyk-Czepas</surname><given-names>J.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name></person-group><article-title>Bufadienolides of Kalanchoe species: An overview of chemical structure, biological activity and prospects for pharmacological use</article-title><source>Phytochem. Rev.</source><year>2017</year><volume>16</volume><fpage>1155</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1007/s11101-017-9525-1</pub-id><pub-id pub-id-type="pmid">29200987</pub-id></element-citation></ref><ref id="B69-pharmaceuticals-13-00444"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bopda</surname><given-names>O.S.M.</given-names></name><name><surname>Longo</surname><given-names>F.</given-names></name><name><surname>Bella</surname><given-names>T.N.</given-names></name><name><surname>Edzah</surname><given-names>P.M.O.</given-names></name><name><surname>Ta&#x000ef;we</surname><given-names>G.S.</given-names></name><name><surname>Bilanda</surname><given-names>D.C.</given-names></name><name><surname>Tom</surname><given-names>E.N.L.</given-names></name><name><surname>Kamtchouing</surname><given-names>P.</given-names></name><name><surname>Dimo</surname><given-names>T.</given-names></name></person-group><article-title>Antihypertensive activities of the aqueous extract of <italic>Kalanchoe pinnata</italic> (Crassulaceae) in high salt-loaded rats</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>153</volume><fpage>400</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.02.041</pub-id><pub-id pub-id-type="pmid">24583107</pub-id></element-citation></ref><ref id="B70-pharmaceuticals-13-00444"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziejczyk-Czepas</surname><given-names>J.</given-names></name><name><surname>Sieradzka</surname><given-names>M.</given-names></name><name><surname>Moniuszko-Szajwaj</surname><given-names>B.</given-names></name><name><surname>Pecio</surname><given-names>&#x00141;.</given-names></name><name><surname>Ponczek</surname><given-names>M.B.</given-names></name><name><surname>Nowak</surname><given-names>P.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name></person-group><article-title>Bufadienolides from <italic>Kalanchoe daigremontiana</italic> as thrombin inhibitors&#x02014;In vitro and in silico study</article-title><source>Int. J. Biol. Macromol.</source><year>2017</year><volume>99</volume><fpage>141</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.02.051</pub-id><pub-id pub-id-type="pmid">28223215</pub-id></element-citation></ref><ref id="B71-pharmaceuticals-13-00444"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>P.C.</given-names></name><name><surname>Kuo</surname><given-names>T.H.</given-names></name><name><surname>Su</surname><given-names>C.R.</given-names></name><name><surname>Liou</surname><given-names>M.J.</given-names></name><name><surname>Wu</surname><given-names>T.S.</given-names></name></person-group><article-title>Cytotoxic principles and &#x003b1;-pyrone ring-opening derivatives of bufadienolides from Kalanchoe hybrida</article-title><source>Tetrahedron</source><year>2008</year><volume>64</volume><fpage>3392</fpage><lpage>3396</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2008.01.090</pub-id></element-citation></ref><ref id="B72-pharmaceuticals-13-00444"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>N.P.</given-names></name><name><surname>Dixit</surname><given-names>V.K.</given-names></name></person-group><article-title>Hepatoprotective activity of leaves of Kalanchoe pinnata Pers</article-title><source>J. Ethnopharmacol.</source><year>2003</year><volume>86</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(03)00074-6</pub-id><pub-id pub-id-type="pmid">12738087</pub-id></element-citation></ref><ref id="B73-pharmaceuticals-13-00444"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>N.</given-names></name><name><surname>Sparks</surname><given-names>J.</given-names></name><name><surname>Omoruyi</surname><given-names>F.</given-names></name></person-group><article-title>Hypoglycemic and hypocholesterolemic activities of the aqueous preparation of <italic>Kalanchoe pinnata</italic> leaves in streptozotocin-induced diabetic rats</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2015</year><volume>5</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(15)30162-3</pub-id></element-citation></ref><ref id="B74-pharmaceuticals-13-00444"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartwal</surname><given-names>A.</given-names></name><name><surname>Mall</surname><given-names>R.</given-names></name><name><surname>Lohani</surname><given-names>P.</given-names></name><name><surname>Guru</surname><given-names>S.K.</given-names></name><name><surname>Arora</surname><given-names>S.</given-names></name></person-group><article-title>Role of Secondary Metabolites and Brassinosteroids in Plant Defense Against Environmental Stresses</article-title><source>J. Plant Growth Regul.</source><year>2013</year><volume>32</volume><fpage>216</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1007/s00344-012-9272-x</pub-id></element-citation></ref><ref id="B75-pharmaceuticals-13-00444"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nile</surname><given-names>S.H.</given-names></name><name><surname>Park</surname><given-names>S.W.</given-names></name></person-group><article-title>Edible berries: Bioactive components and their effect on human health</article-title><source>Nutrition</source><year>2014</year><volume>30</volume><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2013.04.007</pub-id><?supplied-pmid 24012283?><pub-id pub-id-type="pmid">24012283</pub-id></element-citation></ref><ref id="B76-pharmaceuticals-13-00444"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000fc;rer</surname><given-names>K.</given-names></name><name><surname>Sim&#x000f5;es-W&#x000fc;st</surname><given-names>A.P.</given-names></name><name><surname>Von Mandach</surname><given-names>U.</given-names></name><name><surname>Hamburger</surname><given-names>M.</given-names></name><name><surname>Potterat</surname><given-names>O.</given-names></name></person-group><article-title><italic>Bryophyllum pinnatum</italic> and related species used in anthroposophic medicine: Constituents, pharmacological activities, and clinical efficacy</article-title><source>Planta Med.</source><year>2016</year><volume>82</volume><fpage>930</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1055/s-0042-106727</pub-id><pub-id pub-id-type="pmid">27220081</pub-id></element-citation></ref><ref id="B77-pharmaceuticals-13-00444"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanowicz-Hajduk</surname><given-names>J.</given-names></name><name><surname>Asztemborska</surname><given-names>M.</given-names></name><name><surname>Krauze-Baranowska</surname><given-names>M.</given-names></name><name><surname>Godlewska</surname><given-names>S.</given-names></name><name><surname>Gucwa</surname><given-names>M.</given-names></name><name><surname>Moniuszko-Szajwaj</surname><given-names>B.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name><name><surname>Ochocka</surname><given-names>J.R.</given-names></name></person-group><article-title>Identification of flavonoids and bufadienolides and cytotoxic effects of <italic>Kalanchoe daigremontiana</italic> extracts on human cancer cell lines</article-title><source>Planta Med.</source><year>2020</year><volume>86</volume><fpage>239</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1055/a-1099-9786</pub-id><?supplied-pmid 31994149?><pub-id pub-id-type="pmid">31994149</pub-id></element-citation></ref><ref id="B78-pharmaceuticals-13-00444"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>J.M.</given-names></name><name><surname>dos Santos Nascimento</surname><given-names>L.B.</given-names></name><name><surname>Casanova</surname><given-names>L.M.</given-names></name><name><surname>Leal-Costa</surname><given-names>M.V.</given-names></name><name><surname>Costa</surname><given-names>S.S.</given-names></name><name><surname>Tavares</surname><given-names>E.S.</given-names></name></person-group><article-title>Differential distribution of flavonoids and phenolic acids in leaves of Kalanchoe delagoensis Ecklon &#x00026; Zeyher (Crassulaceae)</article-title><source>Microsc. Microanal.</source><year>2020</year><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="B79-pharmaceuticals-13-00444"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>A.K.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Iyer</surname><given-names>S.V.</given-names></name><name><surname>Sudani</surname><given-names>R.J.</given-names></name><name><surname>Vaidya</surname><given-names>S.K.</given-names></name></person-group><article-title>Pharmacognostical, Phytochemical and Pharmacological Review on <italic>Bryophyllum pinnata</italic></article-title><source>Int. J. Pharm. Biol. Arch.</source><year>2012</year><volume>3</volume><fpage>423</fpage><lpage>433</lpage></element-citation></ref><ref id="B80-pharmaceuticals-13-00444"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Losada-Barreiro</surname><given-names>S.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name><name><surname>Bravo-D&#x000ed;az</surname><given-names>C.</given-names></name></person-group><article-title>Adsorption of gallic acid, propyl gallate and polyphenols from <italic>Bryophyllum</italic> extracts on activated carbon</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41598-019-51322-6</pub-id><pub-id pub-id-type="pmid">30626917</pub-id></element-citation></ref><ref id="B81-pharmaceuticals-13-00444"><label>81.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Lozano-Milo</surname><given-names>E.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name><name><surname>Tojo</surname><given-names>C.</given-names></name><name><surname>Losada-Barreiro</surname><given-names>S.</given-names></name><name><surname>Bravo-D&#x000ed;az</surname><given-names>C.</given-names></name></person-group><article-title>Plant antioxidants in food emulsions</article-title><source>Some New Aspects of Colloidal Systems in Foods</source><person-group person-group-type="editor"><name><surname>Milani</surname><given-names>J.</given-names></name></person-group><publisher-name>IntechOpen</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2018</year><fpage>11</fpage><lpage>29</lpage></element-citation></ref><ref id="B82-pharmaceuticals-13-00444"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernetskyy</surname><given-names>M.</given-names></name><name><surname>Wo&#x0017a;niak</surname><given-names>A.</given-names></name><name><surname>Skalska-Kami&#x00144;ska</surname><given-names>A.</given-names></name><name><surname>&#x0017b;uraw</surname><given-names>B.</given-names></name><name><surname>Blicharska</surname><given-names>E.</given-names></name><name><surname>Rejdak</surname><given-names>R.</given-names></name><name><surname>Donica</surname><given-names>H.</given-names></name><name><surname>Weryszko-Chmielewska</surname><given-names>E.</given-names></name></person-group><article-title>Structure of leaves and phenolic acids in Kalancho&#x000eb; daigremontiana Raym.-Hamet &#x00026; H. Perrier</article-title><source>Acta Sci. Pol. Hortorum Cultus</source><year>2018</year><volume>17</volume><fpage>137</fpage><lpage>155</lpage></element-citation></ref><ref id="B83-pharmaceuticals-13-00444"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonache</surname><given-names>M.A.</given-names></name><name><surname>Moreno-Fern&#x000e1;ndez</surname><given-names>S.</given-names></name><name><surname>Miguel</surname><given-names>M.</given-names></name><name><surname>Sabater-Mu&#x000f1;oz</surname><given-names>B.</given-names></name><name><surname>Gonz&#x000e1;lez-Mu&#x000f1;iz</surname><given-names>R.</given-names></name></person-group><article-title>Small Library of Triazolyl Polyphenols Correlating Antioxidant Activity and Stability with Number and Position of Hydroxyl Groups</article-title><source>ACS Comb. Sci.</source><year>2018</year><volume>20</volume><fpage>694</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1021/acscombsci.8b00118</pub-id><pub-id pub-id-type="pmid">30372022</pub-id></element-citation></ref><ref id="B84-pharmaceuticals-13-00444"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;z&#x000e7;elik</surname><given-names>B.</given-names></name><name><surname>Kartal</surname><given-names>M.</given-names></name><name><surname>Orhan</surname><given-names>I.</given-names></name></person-group><article-title>Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids</article-title><source>Pharm. Biol.</source><year>2011</year><volume>49</volume><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.3109/13880209.2010.519390</pub-id><?supplied-pmid 21391841?><pub-id pub-id-type="pmid">21391841</pub-id></element-citation></ref><ref id="B85-pharmaceuticals-13-00444"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cueva</surname><given-names>C.</given-names></name><name><surname>Moreno-Arribas</surname><given-names>M.V.</given-names></name><name><surname>Mart&#x000ed;n-&#x000c1;lvarez</surname><given-names>P.J.</given-names></name><name><surname>Bills</surname><given-names>G.</given-names></name><name><surname>Vicente</surname><given-names>M.F.</given-names></name><name><surname>Basilio</surname><given-names>A.</given-names></name><name><surname>Rivas</surname><given-names>C.L.</given-names></name><name><surname>Requena</surname><given-names>T.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>J.M.</given-names></name><name><surname>Bartolom&#x000e9;</surname><given-names>B.</given-names></name></person-group><article-title>Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria</article-title><source>Res. Microbiol.</source><year>2010</year><volume>161</volume><fpage>372</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2010.04.006</pub-id><?supplied-pmid 20451604?><pub-id pub-id-type="pmid">20451604</pub-id></element-citation></ref><ref id="B86-pharmaceuticals-13-00444"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudnic</surname><given-names>I.</given-names></name><name><surname>Modun</surname><given-names>D.</given-names></name><name><surname>Rastija</surname><given-names>V.</given-names></name><name><surname>Vukovic</surname><given-names>J.</given-names></name><name><surname>Brizic</surname><given-names>I.</given-names></name><name><surname>Katalinic</surname><given-names>V.</given-names></name><name><surname>Kozina</surname><given-names>B.</given-names></name><name><surname>Medic-Saric</surname><given-names>M.</given-names></name><name><surname>Boban</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidative and vasodilatory effects of phenolic acids in wine</article-title><source>Food Chem.</source><year>2010</year><volume>119</volume><fpage>1205</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2009.08.038</pub-id></element-citation></ref><ref id="B87-pharmaceuticals-13-00444"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>C.A.</given-names></name><name><surname>Gir&#x000e3;o Da Cruz</surname><given-names>T.G.</given-names></name><name><surname>Andrade</surname><given-names>J.L.</given-names></name><name><surname>Milhazes</surname><given-names>N.</given-names></name><name><surname>Borges</surname><given-names>F.</given-names></name><name><surname>Marques</surname><given-names>M.P.M.</given-names></name></person-group><article-title>Anticancer Activity of Phenolic Acids of Natural or Synthetic Origin: A Structure-Activity Study</article-title><source>J. Med. Chem.</source><year>2003</year><volume>46</volume><fpage>5395</fpage><lpage>5401</lpage><pub-id pub-id-type="doi">10.1021/jm030956v</pub-id><?supplied-pmid 14640548?><pub-id pub-id-type="pmid">14640548</pub-id></element-citation></ref><ref id="B88-pharmaceuticals-13-00444"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Abdellaoui</surname><given-names>S.</given-names></name><name><surname>Destandau</surname><given-names>E.</given-names></name><name><surname>Toribio</surname><given-names>A.</given-names></name><name><surname>Elfakir</surname><given-names>C.</given-names></name><name><surname>Lafosse</surname><given-names>M.</given-names></name><name><surname>Renimel</surname><given-names>I.</given-names></name><name><surname>Andr&#x000e9;</surname><given-names>P.</given-names></name><name><surname>Cancellieri</surname><given-names>P.</given-names></name><name><surname>Landemarre</surname><given-names>L.</given-names></name></person-group><article-title>Bioactive molecules in <italic>Kalanchoe pinnata</italic> leaves: Extraction, purification, and identification</article-title><source>Anal. Bioanal. Chem.</source><year>2010</year><volume>398</volume><fpage>1329</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1007/s00216-010-4047-3</pub-id><pub-id pub-id-type="pmid">20714893</pub-id></element-citation></ref><ref id="B89-pharmaceuticals-13-00444"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omojokun</surname><given-names>O.S.</given-names></name><name><surname>Oboh</surname><given-names>G.</given-names></name><name><surname>Ademiluyi</surname><given-names>A.O.</given-names></name><name><surname>Oladele</surname><given-names>J.O.</given-names></name><name><surname>Boligon</surname><given-names>A.A.</given-names></name></person-group><article-title>Impact of drying processes on <italic><italic>Bryophyllum</italic> pinnatum</italic> phenolic constituents and its anti-inflammatory and antioxidative activities in human erythrocytes</article-title><source>J. Food Biochem.</source><year>2020</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1111/jfbc.13298</pub-id><?supplied-pmid 32515507?><pub-id pub-id-type="pmid">32515507</pub-id></element-citation></ref><ref id="B90-pharmaceuticals-13-00444"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000fc;rer</surname><given-names>K.</given-names></name><name><surname>Raith</surname><given-names>M.</given-names></name><name><surname>Brenneisen</surname><given-names>R.</given-names></name><name><surname>Mennet</surname><given-names>M.</given-names></name><name><surname>Sim&#x000f5;es-W&#x000fc;st</surname><given-names>A.P.</given-names></name><name><surname>Von Mandach</surname><given-names>U.</given-names></name><name><surname>Hamburger</surname><given-names>M.</given-names></name><name><surname>Potterat</surname><given-names>O.</given-names></name></person-group><article-title>Two new flavonol glycosides and a metabolite profile of <italic>Bryophyllum pinnatum</italic>, a phytotherapeutic used in obstetrics and gynaecology</article-title><source>Planta Med.</source><year>2013</year><volume>79</volume><fpage>1565</fpage><lpage>1571</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1350808</pub-id><pub-id pub-id-type="pmid">24072500</pub-id></element-citation></ref><ref id="B91-pharmaceuticals-13-00444"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e4;</surname><given-names>W.</given-names></name><name><surname>Dettner</surname><given-names>K.</given-names></name><name><surname>Pfeifer</surname><given-names>P.</given-names></name></person-group><article-title>Intra- and Interspecific Allelochemical Effects in Three Kalanchoe-Species (Crassulaceae)</article-title><source>Zeitschrift fur Naturforsch. Sect. C J. Biosci.</source><year>1997</year><volume>52</volume><fpage>441</fpage><lpage>449</lpage></element-citation></ref><ref id="B92-pharmaceuticals-13-00444"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katrucha</surname><given-names>E.M.</given-names></name><name><surname>Lopes</surname><given-names>J.</given-names></name><name><surname>Paim</surname><given-names>M.</given-names></name><name><surname>dos Santos</surname><given-names>J.C.</given-names></name><name><surname>Siebert</surname><given-names>D.A.</given-names></name><name><surname>Micke</surname><given-names>G.A.</given-names></name><name><surname>Vitali</surname><given-names>L.</given-names></name><name><surname>Alberton</surname><given-names>M.D.</given-names></name><name><surname>Tenfen</surname><given-names>A.</given-names></name></person-group><article-title>Phenolic profile by HPLC-ESI-MS/MS and enzymatic inhibitory effect of <italic>Bryophyllum delagoense</italic></article-title><source>Nat. Prod. Res.</source><year>2020</year><volume>0</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/14786419.2020.1729147</pub-id></element-citation></ref><ref id="B93-pharmaceuticals-13-00444"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elansary</surname><given-names>H.O.</given-names></name><name><surname>Szopa</surname><given-names>A.</given-names></name><name><surname>Kubica</surname><given-names>P.</given-names></name><name><surname>Ekiert</surname><given-names>H.</given-names></name><name><surname>Ali</surname><given-names>H.M.</given-names></name><name><surname>Elshikh</surname><given-names>M.S.</given-names></name><name><surname>Abdel-Salam</surname><given-names>E.M.</given-names></name><name><surname>El-Esawi</surname><given-names>M.</given-names></name><name><surname>El-Ansary</surname><given-names>D.O.</given-names></name></person-group><article-title>Bioactivities of Traditional Medicinal Plants in Alexandria</article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2018</year><volume>2018</volume><pub-id pub-id-type="doi">10.1155/2018/1463579</pub-id></element-citation></ref><ref id="B94-pharmaceuticals-13-00444"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chibli</surname><given-names>L.A.</given-names></name><name><surname>Rodrigues</surname><given-names>K.C.M.</given-names></name><name><surname>Gasparetto</surname><given-names>C.M.</given-names></name><name><surname>Pinto</surname><given-names>N.C.C.</given-names></name><name><surname>Fabri</surname><given-names>R.L.</given-names></name><name><surname>Scio</surname><given-names>E.</given-names></name><name><surname>Alves</surname><given-names>M.S.</given-names></name><name><surname>Del-Vechio-Vieira</surname><given-names>G.</given-names></name><name><surname>Sousa</surname><given-names>O.V.</given-names></name></person-group><article-title>Anti-inflammatory effects of <italic>Bryophyllum pinnatum</italic> (Lam.) Oken ethanol extract in acute and chronic cutaneous inflammation</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>154</volume><fpage>330</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.03.035</pub-id><?supplied-pmid 24727190?><pub-id pub-id-type="pmid">24727190</pub-id></element-citation></ref><ref id="B95-pharmaceuticals-13-00444"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nascimento</surname><given-names>L.B.d.S.</given-names></name><name><surname>de Aguiar</surname><given-names>P.F.</given-names></name><name><surname>Leal-Costa</surname><given-names>M.V.</given-names></name><name><surname>Coutinho</surname><given-names>M.A.S.</given-names></name><name><surname>Borsodi</surname><given-names>M.P.G.</given-names></name><name><surname>Rossi-Bergmann</surname><given-names>B.</given-names></name><name><surname>Tavares</surname><given-names>E.S.</given-names></name><name><surname>Costa</surname><given-names>S.S.</given-names></name></person-group><article-title>Optimization of Aqueous Extraction from Kalanchoe pinnata Leaves to Obtain the Highest Content of an Anti-inflammatory Flavonoid using a Response Surface Model</article-title><source>Phytochem. Anal.</source><year>2018</year><volume>29</volume><fpage>308</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">29349835</pub-id></element-citation></ref><ref id="B96-pharmaceuticals-13-00444"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>A.H.</given-names></name><name><surname>Olsen</surname><given-names>C.E.</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>B.L.</given-names></name></person-group><article-title>Flavonoids in flowers of 16 Kalancho&#x000eb; blossfeldiana varieties</article-title><source>Phytochemistry</source><year>2005</year><volume>66</volume><fpage>2829</fpage><lpage>2835</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2005.09.041</pub-id><?supplied-pmid 16297414?><pub-id pub-id-type="pmid">16297414</pub-id></element-citation></ref><ref id="B97-pharmaceuticals-13-00444"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T.Y.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Bi</surname><given-names>K.S.</given-names></name></person-group><article-title>Bioactive flavonoids in medicinal plants: Structure, activity and biological fate</article-title><source>Asian J. Pharm. Sci.</source><year>2018</year><volume>13</volume><fpage>12</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.ajps.2017.08.004</pub-id><pub-id pub-id-type="pmid">32104374</pub-id></element-citation></ref><ref id="B98-pharmaceuticals-13-00444"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname><given-names>W.</given-names></name><name><surname>Sies</surname><given-names>H.</given-names></name></person-group><article-title>Carotenoids and flavonoids contribute to nutritional protection against skin damage from sunlight</article-title><source>Mol. Biotechnol.</source><year>2007</year><volume>37</volume><fpage>26</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1007/s12033-007-0051-z</pub-id><pub-id pub-id-type="pmid">17914160</pub-id></element-citation></ref><ref id="B99-pharmaceuticals-13-00444"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandi&#x00107;</surname><given-names>L.</given-names></name><name><surname>Sad&#x0017e;ak</surname><given-names>A.</given-names></name><name><surname>Strasser</surname><given-names>V.</given-names></name><name><surname>Baranovi&#x00107;</surname><given-names>G.</given-names></name><name><surname>Jura&#x00161;in</surname><given-names>D.D.</given-names></name><name><surname>Sikiri&#x00107;</surname><given-names>M.D.</given-names></name><name><surname>&#x00160;egota</surname><given-names>S.</given-names></name></person-group><article-title>Enhanced protection of biological membranes during lipid peroxidation: Study of the interactions between flavonoid loaded mesoporous silica nanoparticles and model cell membranes</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>2709</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20112709</pub-id></element-citation></ref><ref id="B100-pharmaceuticals-13-00444"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherrak</surname><given-names>S.A.</given-names></name><name><surname>Mokhtari-Soulimane</surname><given-names>N.</given-names></name><name><surname>Berroukeche</surname><given-names>F.</given-names></name><name><surname>Bensenane</surname><given-names>B.</given-names></name><name><surname>Cherbonnel</surname><given-names>A.</given-names></name><name><surname>Merzouk</surname><given-names>H.</given-names></name><name><surname>Elhabiri</surname><given-names>M.</given-names></name></person-group><article-title>In vitro antioxidant versus metal ion chelating properties of flavonoids: A structure-activity investigation</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0165575</pub-id></element-citation></ref><ref id="B101-pharmaceuticals-13-00444"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Losada-Barreiro</surname><given-names>S.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name><name><surname>Bravo-D&#x000ed;az</surname><given-names>C.</given-names></name></person-group><article-title>Cyclodextrin-elicited <italic>Bryophyllum</italic> suspension cultured cells: Enhancement of the production of bioactive compounds</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>5180</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20205180</pub-id></element-citation></ref><ref id="B102-pharmaceuticals-13-00444"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatsimo</surname><given-names>S.J.N.</given-names></name><name><surname>Tamokou</surname><given-names>J.D.D.</given-names></name><name><surname>Havyarimana</surname><given-names>L.</given-names></name><name><surname>Csupor</surname><given-names>D.</given-names></name><name><surname>Forgo</surname><given-names>P.</given-names></name><name><surname>Hohmann</surname><given-names>J.</given-names></name><name><surname>Kuiate</surname><given-names>J.R.</given-names></name><name><surname>Tane</surname><given-names>P.</given-names></name></person-group><article-title>Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from <italic>Bryophyllum pinnatum</italic></article-title><source>BMC Res. Notes</source><year>2012</year><volume>5</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1186/1756-0500-5-158</pub-id><pub-id pub-id-type="pmid">22214347</pub-id></element-citation></ref><ref id="B103-pharmaceuticals-13-00444"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushnie</surname><given-names>T.P.T.</given-names></name><name><surname>Lamb</surname><given-names>A.J.</given-names></name></person-group><article-title>Antimicrobial activity of flavonoids</article-title><source>Int. J. Antimicrob. Agents</source><year>2005</year><volume>26</volume><fpage>343</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2005.09.002</pub-id><pub-id pub-id-type="pmid">16323269</pub-id></element-citation></ref><ref id="B104-pharmaceuticals-13-00444"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>D.D.</given-names></name><name><surname>&#x000d6;z&#x000e7;elik</surname><given-names>B.</given-names></name><name><surname>&#x000d6;zgen</surname><given-names>S.</given-names></name><name><surname>Ergun</surname><given-names>F.</given-names></name></person-group><article-title>Antibacterial, antifungal, and antiviral activities of some flavonoids</article-title><source>Microbiol. Res.</source><year>2010</year><volume>165</volume><fpage>496</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2009.09.002</pub-id><?supplied-pmid 19840899?><pub-id pub-id-type="pmid">19840899</pub-id></element-citation></ref><ref id="B105-pharmaceuticals-13-00444"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plochmann</surname><given-names>K.</given-names></name><name><surname>Korte</surname><given-names>G.</given-names></name><name><surname>Koutsilieri</surname><given-names>E.</given-names></name><name><surname>Richling</surname><given-names>E.</given-names></name><name><surname>Riederer</surname><given-names>P.</given-names></name><name><surname>Rethwilm</surname><given-names>A.</given-names></name><name><surname>Schreier</surname><given-names>P.</given-names></name><name><surname>Scheller</surname><given-names>C.</given-names></name></person-group><article-title>Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells</article-title><source>Arch. Biochem. Biophys.</source><year>2007</year><volume>460</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2007.02.003</pub-id><?supplied-pmid 17353006?><pub-id pub-id-type="pmid">17353006</pub-id></element-citation></ref><ref id="B106-pharmaceuticals-13-00444"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>M.H.</given-names></name><name><surname>Lai</surname><given-names>C.S.</given-names></name><name><surname>Ho</surname><given-names>C.T.</given-names></name></person-group><article-title>Anti-inflammatory activity of natural dietary flavonoids</article-title><source>Food Funct.</source><year>2010</year><volume>1</volume><fpage>15</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1039/c0fo00103a</pub-id><?supplied-pmid 21776454?><pub-id pub-id-type="pmid">21776454</pub-id></element-citation></ref><ref id="B107-pharmaceuticals-13-00444"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testai</surname><given-names>L.</given-names></name></person-group><article-title>Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection</article-title><source>Life Sci.</source><year>2015</year><volume>135</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2015.04.017</pub-id><?supplied-pmid 26006042?><pub-id pub-id-type="pmid">26006042</pub-id></element-citation></ref><ref id="B108-pharmaceuticals-13-00444"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>P.V.A.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Gilbert</surname><given-names>E.R.</given-names></name></person-group><article-title>Recent advances in understanding the anti-diabetic actions of dietary flavonoids</article-title><source>J. Nutr. Biochem.</source><year>2013</year><volume>24</volume><fpage>1777</fpage><lpage>1789</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2013.06.003</pub-id><pub-id pub-id-type="pmid">24029069</pub-id></element-citation></ref><ref id="B109-pharmaceuticals-13-00444"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzitano</surname><given-names>M.F.</given-names></name><name><surname>Tinoco</surname><given-names>L.W.</given-names></name><name><surname>Guette</surname><given-names>C.</given-names></name><name><surname>Kaiser</surname><given-names>C.R.</given-names></name><name><surname>Rossi-Bergmann</surname><given-names>B.</given-names></name><name><surname>Costa</surname><given-names>S.S.</given-names></name></person-group><article-title>The antileishmanial activity assessment of unusual flavonoids from <italic>Kalanchoe pinnata</italic></article-title><source>Phytochemistry</source><year>2006</year><volume>67</volume><fpage>2071</fpage><lpage>2077</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2006.06.027</pub-id><pub-id pub-id-type="pmid">16930642</pub-id></element-citation></ref><ref id="B110-pharmaceuticals-13-00444"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>R.T.</given-names></name><name><surname>Coutinho</surname><given-names>M.A.S.</given-names></name><name><surname>Malvar</surname><given-names>D.D.C.</given-names></name><name><surname>Costa</surname><given-names>E.A.</given-names></name><name><surname>Florentino</surname><given-names>I.F.</given-names></name><name><surname>Costa</surname><given-names>S.S.</given-names></name><name><surname>Vanderlinde</surname><given-names>F.A.</given-names></name></person-group><article-title>Mechanisms underlying the antinociceptive, antiedematogenic, and anti-inflammatory activity of the main flavonoid from <italic>Kalanchoe pinnata</italic></article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2014</year><volume>2014</volume><pub-id pub-id-type="doi">10.1155/2014/429256</pub-id></element-citation></ref><ref id="B111-pharmaceuticals-13-00444"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogungbamila</surname><given-names>F.O.</given-names></name><name><surname>Onawunmi</surname><given-names>G.O.</given-names></name><name><surname>Adeosun</surname><given-names>O.</given-names></name></person-group><article-title>A new acylated flavan-3-ol from <italic>Bryophyllum pinnatum</italic></article-title><source>Nat. Prod. Lett.</source><year>1997</year><volume>10</volume><fpage>201</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1080/10575639708041195</pub-id></element-citation></ref><ref id="B112-pharmaceuticals-13-00444"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nascimento</surname><given-names>L.B.D.S.</given-names></name><name><surname>Leal-Costa</surname><given-names>M.V.</given-names></name><name><surname>Menezes</surname><given-names>E.A.</given-names></name><name><surname>Lopes</surname><given-names>V.R.</given-names></name><name><surname>Muzitano</surname><given-names>M.F.</given-names></name><name><surname>Costa</surname><given-names>S.S.</given-names></name><name><surname>Tavares</surname><given-names>E.S.</given-names></name></person-group><article-title>Ultraviolet-B radiation effects on phenolic profile and flavonoid content of <italic>Kalanchoe pinnata</italic></article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2015</year><volume>148</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2015.03.011</pub-id></element-citation></ref><ref id="B113-pharmaceuticals-13-00444"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henn</surname><given-names>D.</given-names></name><name><surname>Venter</surname><given-names>A.</given-names></name><name><surname>Botha</surname><given-names>C.</given-names></name></person-group><article-title>In vitro cytotoxicity induced by the bufadienolides 1&#x003b1;,2&#x003b1;-epoxyscillirosidine and lanceotoxin b on rat myocardial and mouse neuroblastoma cell lines</article-title><source>Toxins (Basel).</source><year>2019</year><volume>11</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.3390/toxins11010014</pub-id></element-citation></ref><ref id="B114-pharmaceuticals-13-00444"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oufir</surname><given-names>M.</given-names></name><name><surname>Seiler</surname><given-names>C.</given-names></name><name><surname>Gerodetti</surname><given-names>M.</given-names></name><name><surname>Gerber</surname><given-names>J.</given-names></name><name><surname>F&#x000fc;rer</surname><given-names>K.</given-names></name><name><surname>Mennet-von Eiff</surname><given-names>M.</given-names></name><name><surname>Elsas</surname><given-names>S.M.</given-names></name><name><surname>Brenneisen</surname><given-names>R.</given-names></name><name><surname>Von Mandach</surname><given-names>U.</given-names></name><name><surname>Hamburger</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Quantification of Bufadienolides in <italic>Bryophyllum pinnatum</italic> Leaves and Manufactured Products by UHPLC-ESIMS/MS</article-title><source>Planta Med.</source><year>2015</year><volume>81</volume><fpage>1190</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1055/s-0035-1546126</pub-id><?supplied-pmid 26132852?><pub-id pub-id-type="pmid">26132852</pub-id></element-citation></ref><ref id="B115-pharmaceuticals-13-00444"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>P.L.</given-names></name><name><surname>Hsu</surname><given-names>Y.L.</given-names></name><name><surname>Wu</surname><given-names>T.S.</given-names></name><name><surname>Bastow</surname><given-names>K.F.</given-names></name><name><surname>Lee</surname><given-names>K.H.</given-names></name></person-group><article-title>Kalanchosides A-C, new cytotoxic bufadienolides from the aerial parts of <italic>Kalanchoe gracilis</italic></article-title><source>Org. Lett.</source><year>2006</year><volume>8</volume><fpage>5207</fpage><lpage>5210</lpage><pub-id pub-id-type="doi">10.1021/ol061873m</pub-id><?supplied-pmid 17078679?><pub-id pub-id-type="pmid">17078679</pub-id></element-citation></ref><ref id="B116-pharmaceuticals-13-00444"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Ren</surname><given-names>T.</given-names></name><name><surname>Qu</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name></person-group><article-title>A bufadienolide-loaded submicron emulsion for oral administration: Stability, antitumor efficacy and toxicity</article-title><source>Int. J. Pharm.</source><year>2015</year><volume>479</volume><fpage>52</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2014.12.054</pub-id><?supplied-pmid 25545797?><pub-id pub-id-type="pmid">25545797</pub-id></element-citation></ref><ref id="B117-pharmaceuticals-13-00444"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bick</surname><given-names>R.J.</given-names></name><name><surname>Poindexter</surname><given-names>B.J.</given-names></name><name><surname>Sweney</surname><given-names>R.R.</given-names></name><name><surname>Dasgupta</surname><given-names>A.</given-names></name></person-group><article-title>Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: Cardiotoxicity due to more than Na, K-ATPase blocking</article-title><source>Life Sci.</source><year>2002</year><volume>72</volume><fpage>699</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(02)02302-0</pub-id><pub-id pub-id-type="pmid">12467910</pub-id></element-citation></ref><ref id="B118-pharmaceuticals-13-00444"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>R.A.</given-names></name><name><surname>Franke</surname><given-names>F.P.</given-names></name><name><surname>Dunster</surname><given-names>P.J.</given-names></name></person-group><article-title>The toxicity to cattle and bufadienolide content of six <italic>Bryophyllum</italic> species</article-title><source>Aust. Vet. J.</source><year>1987</year><volume>64</volume><fpage>298</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1111/j.1751-0813.1987.tb07330.x</pub-id><pub-id pub-id-type="pmid">3439945</pub-id></element-citation></ref><ref id="B119-pharmaceuticals-13-00444"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>R.A.</given-names></name><name><surname>Franke</surname><given-names>F.P.</given-names></name><name><surname>Dunster</surname><given-names>P.J.</given-names></name></person-group><article-title>The toxicity for cattle of bufadienolide cardiac glycosides from <italic>Bryophyllum tubiflorum</italic> flowers</article-title><source>Aust. Vet. J.</source><year>1989</year><volume>66</volume><fpage>374</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1111/j.1751-0813.1989.tb09741.x</pub-id><pub-id pub-id-type="pmid">2619654</pub-id></element-citation></ref><ref id="B120-pharmaceuticals-13-00444"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Popescu</surname><given-names>R.</given-names></name><name><surname>Kopp</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Bufadienolides and their antitumor activity</article-title><source>Nat. Prod. Rep.</source><year>2011</year><volume>28</volume><fpage>953</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1039/c0np00032a</pub-id><pub-id pub-id-type="pmid">21416078</pub-id></element-citation></ref><ref id="B121-pharmaceuticals-13-00444"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Weng</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name></person-group><article-title>The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers</article-title><source>Int. J. Pharm.</source><year>2010</year><volume>393</volume><fpage>204</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2010.04.005</pub-id></element-citation></ref><ref id="B122-pharmaceuticals-13-00444"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>W.Y.</given-names></name><name><surname>Fan</surname><given-names>T.Y.</given-names></name><name><surname>Li</surname><given-names>N.G.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Duan</surname><given-names>J.A.</given-names></name><name><surname>Shi</surname><given-names>Z.H.</given-names></name></person-group><article-title>Total synthesis, chemical modification and structure-activity relationship of bufadienolides</article-title><source>Eur. J. Med. Chem.</source><year>2020</year><volume>189</volume><fpage>112038</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112038</pub-id><pub-id pub-id-type="pmid">31945667</pub-id></element-citation></ref><ref id="B123-pharmaceuticals-13-00444"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isah</surname><given-names>T.</given-names></name></person-group><article-title>Stress and defense responses in plant secondary metabolites production</article-title><source>Biol. Res.</source><year>2019</year><volume>52</volume><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/s40659-019-0246-3</pub-id><pub-id pub-id-type="pmid">31358053</pub-id></element-citation></ref><ref id="B124-pharmaceuticals-13-00444"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moniuszko-Szajwaj</surname><given-names>B.</given-names></name><name><surname>Pecio</surname><given-names>&#x00141;.</given-names></name><name><surname>Kowalczyk</surname><given-names>M.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name></person-group><article-title>New bufadienolides isolated from the roots of <italic>Kalanchoe daigremontiana</italic> (Crassulaceae)</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>243</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21030243</pub-id><?supplied-pmid 26927036?><pub-id pub-id-type="pmid">26927036</pub-id></element-citation></ref><ref id="B125-pharmaceuticals-13-00444"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>T.</given-names></name><name><surname>Haruna</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>X.-Z.</given-names></name><name><surname>Chang</surname><given-names>J.-J.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name></person-group><article-title>Antitumor agents, 110, Bryophyllin B, a novel potent cytotoxic bufadienolide from <italic>Bryophyllum pinnatum</italic></article-title><source>J. Nat. Prod.</source><year>1989</year><volume>52</volume><fpage>1071</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1021/np50065a025</pub-id><?supplied-pmid 2607348?><pub-id pub-id-type="pmid">2607348</pub-id></element-citation></ref><ref id="B126-pharmaceuticals-13-00444"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanowicz-Hajduk</surname><given-names>J.</given-names></name><name><surname>Hering</surname><given-names>A.</given-names></name><name><surname>Gucwa</surname><given-names>M.</given-names></name><name><surname>Ha&#x00142;asa</surname><given-names>R.</given-names></name><name><surname>Soluch</surname><given-names>A.</given-names></name><name><surname>Kowalczyk</surname><given-names>M.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name><name><surname>Ochocka</surname><given-names>R.</given-names></name></person-group><article-title>Biological activities of leaf extracts from selected Kalanchoe species and their relationship with bufadienolides content</article-title><source>Pharm. Biol.</source><year>2020</year><volume>58</volume><fpage>732</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1080/13880209.2020.1795208</pub-id><?supplied-pmid 32715869?><pub-id pub-id-type="pmid">32715869</pub-id></element-citation></ref><ref id="B127-pharmaceuticals-13-00444"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.C.</given-names></name><name><surname>Lin</surname><given-names>M.K.</given-names></name><name><surname>Yang</surname><given-names>H.L.</given-names></name><name><surname>Hseu</surname><given-names>Y.C.</given-names></name><name><surname>Liaw</surname><given-names>C.C.</given-names></name><name><surname>Tseng</surname><given-names>Y.H.</given-names></name><name><surname>Tsuzuki</surname><given-names>M.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name></person-group><article-title>Cardenolides and bufadienolide glycosides from <italic>Kalanchoe tubiflora</italic> and evaluation of cytotoxicity</article-title><source>Planta Med.</source><year>2013</year><volume>79</volume><fpage>1362</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1350646</pub-id><?supplied-pmid 23877916?><pub-id pub-id-type="pmid">23877916</pub-id></element-citation></ref><ref id="B128-pharmaceuticals-13-00444"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchev</surname><given-names>A.S.</given-names></name><name><surname>Yordanova</surname><given-names>Z.P.</given-names></name><name><surname>Georgiev</surname><given-names>M.I.</given-names></name></person-group><article-title>Green (cell) factories for advanced production of plant secondary metabolites</article-title><source>Crit. Rev. Biotechnol.</source><year>2020</year><volume>0</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1080/07388551.2020.1731414</pub-id></element-citation></ref><ref id="B129-pharmaceuticals-13-00444"><label>129.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>El Sheikha</surname><given-names>A.F.</given-names></name></person-group><article-title>Medicinal plants: Ethno-uses to biotechnology era</article-title><source>Biotechnology and Production of Anti-Cancer Compounds</source><person-group person-group-type="editor"><name><surname>Malik</surname><given-names>S.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2017</year><fpage>1</fpage><lpage>38</lpage></element-citation></ref><ref id="B130-pharmaceuticals-13-00444"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Natural products: A continuing source of novel drug leads</article-title><source>Biochim. Biophys. Acta Gen. Subj.</source><year>2013</year><volume>1830</volume><fpage>3670</fpage><lpage>3695</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2013.02.008</pub-id></element-citation></ref><ref id="B131-pharmaceuticals-13-00444"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eibl</surname><given-names>R.</given-names></name><name><surname>Meier</surname><given-names>P.</given-names></name><name><surname>Stutz</surname><given-names>I.</given-names></name><name><surname>Schildberger</surname><given-names>D.</given-names></name><name><surname>H&#x000fc;hn</surname><given-names>T.</given-names></name><name><surname>Eibl</surname><given-names>D.</given-names></name></person-group><article-title>Plant cell culture technology in the cosmetics and food industries: Current state and future trends</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>8661</fpage><lpage>8675</lpage><pub-id pub-id-type="doi">10.1007/s00253-018-9279-8</pub-id><pub-id pub-id-type="pmid">30099571</pub-id></element-citation></ref><ref id="B132-pharmaceuticals-13-00444"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karuppusamy</surname><given-names>S.</given-names></name></person-group><article-title>A review on trends in production of secondary metabolites from higher plants by in vitro tissue, organ and cell cultures</article-title><source>J. Med. Plants Res.</source><year>2009</year><volume>3</volume><fpage>1222</fpage><lpage>1239</lpage></element-citation></ref><ref id="B133-pharmaceuticals-13-00444"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorpe</surname><given-names>T.A.</given-names></name></person-group><article-title>History of plant tissue culture</article-title><source>Mol. Biotechnol.</source><year>2007</year><volume>37</volume><fpage>169</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1007/s12033-007-0031-3</pub-id><pub-id pub-id-type="pmid">17914178</pub-id></element-citation></ref><ref id="B134-pharmaceuticals-13-00444"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.H.</given-names></name><name><surname>Tang</surname><given-names>L.P.</given-names></name><name><surname>Zhao</surname><given-names>X.Y.</given-names></name><name><surname>Zhang</surname><given-names>X.S.</given-names></name></person-group><article-title>Plant cell totipotency: Insights into cellular reprogramming</article-title><source>J. Integr. Plant Biol.</source><year>2020</year><volume>00</volume></element-citation></ref><ref id="B135-pharmaceuticals-13-00444"><label>135.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>George</surname><given-names>E.F.</given-names></name><name><surname>Hall</surname><given-names>M.A.</given-names></name><name><surname>De Klerk</surname><given-names>G.-J.</given-names></name></person-group><article-title>Plant tissue culture procedure-background</article-title><source>Plant Propagation by Tissue Culture</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2008</year><fpage>1</fpage><lpage>28</lpage></element-citation></ref><ref id="B136-pharmaceuticals-13-00444"><label>136.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>J.A.T.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name></person-group><article-title>Thin cell layers: The technique</article-title><source>Plant Cell Culture: Essential Methods.</source><person-group person-group-type="editor"><name><surname>Davey</surname><given-names>M.R.</given-names></name><name><surname>Anthony</surname><given-names>P.</given-names></name></person-group><publisher-name>John Wiley &#x00026; Sons</publisher-name><publisher-loc>Chichester, UK</publisher-loc><year>2010</year><fpage>25</fpage><lpage>37</lpage></element-citation></ref><ref id="B137-pharmaceuticals-13-00444"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Lozano-Milo</surname><given-names>E.</given-names></name><name><surname>Landin</surname><given-names>M.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Machine Learning technology reveals the concealed interactions of phytohormones on medicinal plant in vitro organogenesis</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>746</elocation-id><pub-id pub-id-type="doi">10.3390/biom10050746</pub-id><?supplied-pmid 32403395?><pub-id pub-id-type="pmid">32403395</pub-id></element-citation></ref><ref id="B138-pharmaceuticals-13-00444"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulus</surname><given-names>D.</given-names></name></person-group><article-title>Micropropagation of <italic>Kalanchoe tubiflora</italic> (Harvey) Hamet</article-title><source>Nauk. Przyr. Technol.</source><year>2015</year><volume>9</volume><pub-id pub-id-type="doi">10.17306/J.NPT.2015.1.14</pub-id></element-citation></ref><ref id="B139-pharmaceuticals-13-00444"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naz</surname><given-names>S.</given-names></name><name><surname>Javad</surname><given-names>S.</given-names></name><name><surname>Ilyas</surname><given-names>S.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name></person-group><article-title>An efficient protocol for rapid multiplication of <italic>Bryophyllum pinnatum</italic> and <italic>Bryophyllum daigremontianum</italic></article-title><source>Pakistan J. Bot.</source><year>2009</year><volume>41</volume><fpage>2347</fpage><lpage>2355</lpage></element-citation></ref><ref id="B140-pharmaceuticals-13-00444"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frello</surname><given-names>S.</given-names></name><name><surname>Venerus</surname><given-names>E.</given-names></name><name><surname>Serek</surname><given-names>M.</given-names></name></person-group><article-title>Regeneration of various species of Crassulaceae, with special reference to Kalancho&#x000eb;</article-title><source>J. Hortic. Sci. Biotechnol.</source><year>2002</year><volume>77</volume><fpage>204</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1080/14620316.2002.11511480</pub-id></element-citation></ref><ref id="B141-pharmaceuticals-13-00444"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammed</surname><given-names>S.U.B.</given-names></name><name><surname>Choi</surname><given-names>K.-S.</given-names></name><name><surname>Kim</surname><given-names>T.-R.</given-names></name><name><surname>In</surname><given-names>J.-G.</given-names></name><name><surname>Yang</surname><given-names>D.-C.</given-names></name></person-group><article-title>Plant regeneration from leaf explants of <italic>Kalanchoe daigremontiana</italic> Hamet &#x00026; Perrier</article-title><source>Korean J. Med. Crop Sci.</source><year>2006</year><volume>14</volume><fpage>293</fpage><lpage>298</lpage></element-citation></ref><ref id="B142-pharmaceuticals-13-00444"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kefu</surname><given-names>Z.</given-names></name><name><surname>Hai</surname><given-names>F.</given-names></name><name><surname>San</surname><given-names>Z.</given-names></name><name><surname>Jie</surname><given-names>S.</given-names></name></person-group><article-title>Study on the salt and drought tolerance of Suaeda salsa and <italic>Kalanchoe daigremontiana</italic> under iso-osmotic salt and water stress</article-title><source>Plant Sci.</source><year>2003</year><volume>165</volume><fpage>837</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1016/S0168-9452(03)00282-6</pub-id></element-citation></ref><ref id="B143-pharmaceuticals-13-00444"><label>143.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>George</surname><given-names>E.F.</given-names></name><name><surname>Hall</surname><given-names>M.A.</given-names></name><name><surname>De Klerk</surname><given-names>G.-J.</given-names></name></person-group><article-title>The components of plant tissue culture media I: Macro-and micro-nutrients</article-title><source>Plant Propagation by Tissue Culture</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc><year>2008</year><fpage>65</fpage><lpage>113</lpage></element-citation></ref><ref id="B144-pharmaceuticals-13-00444"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nezami-Alanagh</surname><given-names>E.</given-names></name><name><surname>Garoosi</surname><given-names>G.A.</given-names></name><name><surname>Haddad</surname><given-names>R.</given-names></name><name><surname>Maleki</surname><given-names>S.</given-names></name><name><surname>Land&#x000ed;n</surname><given-names>M.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Design of tissue culture media for efficient Prunus rootstock micropropagation using artificial intelligence models</article-title><source>Plant Cell. Tissue Organ Cult.</source><year>2014</year><volume>117</volume><fpage>349</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1007/s11240-014-0444-1</pub-id></element-citation></ref><ref id="B145-pharmaceuticals-13-00444"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murashige</surname><given-names>T.</given-names></name><name><surname>Skoog</surname><given-names>F.</given-names></name></person-group><article-title>A revised medium for rapid growth and bio assays with tobacco tissue cultures</article-title><source>Physiol. Plant.</source><year>1962</year><volume>15</volume><fpage>473</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3054.1962.tb08052.x</pub-id></element-citation></ref><ref id="B146-pharmaceuticals-13-00444"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikenganyia</surname><given-names>E.E.</given-names></name><name><surname>Anikwe</surname><given-names>M.A.N.</given-names></name><name><surname>Omeje</surname><given-names>T.E.</given-names></name><name><surname>Adinde</surname><given-names>J.O.</given-names></name></person-group><article-title>Plant tissue culture regeneration and aseptic techniques</article-title><source>Asian J. Biotechnol. Bioresour. Technol.</source><year>2017</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.9734/AJB2T/2017/31724</pub-id></element-citation></ref><ref id="B147-pharmaceuticals-13-00444"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamborg</surname><given-names>O.L.</given-names></name><name><surname>Murashige</surname><given-names>T.</given-names></name><name><surname>Thorpe</surname><given-names>T.A.</given-names></name><name><surname>Vasil</surname><given-names>I.K.</given-names></name></person-group><article-title>Plant tissue culture media</article-title><source>In Vitro</source><year>1976</year><volume>12</volume><fpage>473</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1007/BF02796489</pub-id><pub-id pub-id-type="pmid">965014</pub-id></element-citation></ref><ref id="B148-pharmaceuticals-13-00444"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nezami-Alanagh</surname><given-names>E.</given-names></name><name><surname>Garoosi</surname><given-names>G.A.</given-names></name><name><surname>Land&#x000ed;n</surname><given-names>M.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Computer-based tools provide new insight into the key factors that cause physiological disorders of pistachio rootstocks cultured in vitro</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/s41598-019-46155-2</pub-id><?supplied-pmid 31278299?><pub-id pub-id-type="pmid">30626917</pub-id></element-citation></ref><ref id="B149-pharmaceuticals-13-00444"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>G.C.</given-names></name><name><surname>Garda</surname><given-names>M.</given-names></name></person-group><article-title>Plant tissue culture media and practices: An overview</article-title><source>Vitr. Cell. Dev. Biol. Plant</source><year>2019</year><volume>55</volume><fpage>242</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1007/s11627-019-09983-5</pub-id></element-citation></ref><ref id="B150-pharmaceuticals-13-00444"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>P.N.</given-names></name><name><surname>Cushman</surname><given-names>J.C.</given-names></name></person-group><article-title>Exploring the relationship between crassulacean acid metabolism (CAM) and mineral nutrition with a special focus on nitrogen</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>4363</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20184363</pub-id><?supplied-pmid 31491972?><pub-id pub-id-type="pmid">31491972</pub-id></element-citation></ref><ref id="B151-pharmaceuticals-13-00444"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>P.N.</given-names></name><name><surname>Smith</surname><given-names>J.A.C.</given-names></name><name><surname>Mercier</surname><given-names>H.</given-names></name></person-group><article-title>Nitrate enhancement of CAM activity in two Kalancho&#x000eb; species is associated with increased vacuolar proton transport capacity</article-title><source>Physiol. Plant.</source><year>2017</year><volume>160</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1111/ppl.12578</pub-id><?supplied-pmid 28393374?><pub-id pub-id-type="pmid">28393374</pub-id></element-citation></ref><ref id="B152-pharmaceuticals-13-00444"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>M.R.A.</given-names></name><name><surname>Ferreira</surname><given-names>M.G.R.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>M.C.M.</given-names></name><name><surname>Lima</surname><given-names>R.A.</given-names></name><name><surname>Oliveira</surname><given-names>C.</given-names></name></person-group><article-title>Callogenesis in leaves of <italic>Kalanchoe pinnata</italic> Lam. by 2, 4-D and BA action</article-title><source>Rev. Bras. Plantas Med.</source><year>2014</year><volume>16</volume><fpage>760</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1590/1983-084x/13_031</pub-id></element-citation></ref><ref id="B153-pharmaceuticals-13-00444"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>P.</given-names></name><name><surname>Lozano-Milo</surname><given-names>E.</given-names></name><name><surname>Landin</surname><given-names>M.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Machine Learning unmasked nutritional imbalances on the medicinal plant <italic>Bryophyllum</italic> sp. cultured in vitro</article-title><source>Front. Plant Sci.</source><year>2020</year><volume>11</volume><fpage>576177</fpage><pub-id pub-id-type="doi">10.3389/fpls.2020.576177</pub-id><pub-id pub-id-type="pmid">33329638</pub-id></element-citation></ref><ref id="B154-pharmaceuticals-13-00444"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedz</surname><given-names>R.P.</given-names></name><name><surname>Evens</surname><given-names>T.J.</given-names></name></person-group><article-title>A solution to the problem of ion</article-title><source>Nat. Methods</source><year>2006</year><volume>3</volume><fpage>34945</fpage><pub-id pub-id-type="doi">10.1038/nmeth0606-417</pub-id></element-citation></ref><ref id="B155-pharmaceuticals-13-00444"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>S.A.</given-names></name><name><surname>Roberts</surname><given-names>S.C.</given-names></name></person-group><article-title>Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules</article-title><source>Plant Biotechnol. J.</source><year>2012</year><volume>10</volume><fpage>249</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1111/j.1467-7652.2011.00664.x</pub-id><pub-id pub-id-type="pmid">22059985</pub-id></element-citation></ref><ref id="B156-pharmaceuticals-13-00444"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namdeo</surname><given-names>A.G.</given-names></name></person-group><article-title>Plant cell elicitation for production of secondary metabolites: A review</article-title><source>Rev. Lit. Arts Am.</source><year>2007</year><volume>1</volume><fpage>69</fpage><lpage>79</lpage></element-citation></ref><ref id="B157-pharmaceuticals-13-00444"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez-Estrada</surname><given-names>K.</given-names></name><name><surname>Vidal-Limon</surname><given-names>H.</given-names></name><name><surname>Hidalgo</surname><given-names>D.</given-names></name><name><surname>Moyano</surname><given-names>E.</given-names></name><name><surname>Golenioswki</surname><given-names>M.</given-names></name><name><surname>Cusid&#x000f3;</surname><given-names>R.M.</given-names></name><name><surname>Palazon</surname><given-names>J.</given-names></name></person-group><article-title>Elicitation, an effective strategy for the biotechnological production of bioactive high-added value compounds in plant cell factories</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>182</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21020182</pub-id><pub-id pub-id-type="pmid">26848649</pub-id></element-citation></ref><ref id="B158-pharmaceuticals-13-00444"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>W.</given-names></name><name><surname>Ming</surname><given-names>Q.L.</given-names></name><name><surname>Lin</surname><given-names>B.</given-names></name><name><surname>Rahman</surname><given-names>K.</given-names></name><name><surname>Zheng</surname><given-names>C.J.</given-names></name><name><surname>Han</surname><given-names>T.</given-names></name><name><surname>Qin</surname><given-names>L.P.</given-names></name></person-group><article-title>Medicinal plant cell suspension cultures: Pharmaceutical applications and high-yielding strategies for the desired secondary metabolites</article-title><source>Crit. Rev. Biotechnol.</source><year>2016</year><volume>36</volume><fpage>215</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.3109/07388551.2014.923986</pub-id><?supplied-pmid 24963701?><pub-id pub-id-type="pmid">24963701</pub-id></element-citation></ref><ref id="B159-pharmaceuticals-13-00444"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giri</surname><given-names>C.C.</given-names></name><name><surname>Zaheer</surname><given-names>M.</given-names></name></person-group><article-title>Chemical elicitors versus secondary metabolite production in vitro using plant cell, tissue and organ cultures: Recent trends and a sky eye view appraisal</article-title><source>Plant Cell. Tissue Organ Cult.</source><year>2016</year><volume>126</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/s11240-016-0985-6</pub-id></element-citation></ref><ref id="B160-pharmaceuticals-13-00444"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconsuelo</surname><given-names>A.</given-names></name><name><surname>Boland</surname><given-names>R.</given-names></name></person-group><article-title>Molecular aspects of the early stages of elicitation of secondary metabolites in plants</article-title><source>Plant Sci.</source><year>2007</year><volume>172</volume><fpage>861</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1016/j.plantsci.2007.01.006</pub-id></element-citation></ref><ref id="B161-pharmaceuticals-13-00444"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narayani</surname><given-names>M.</given-names></name><name><surname>Srivastava</surname><given-names>S.</given-names></name></person-group><article-title>Elicitation: A stimulation of stress in in vitro plant cell/tissue cultures for enhancement of secondary metabolite production</article-title><source>Phytochem. Rev.</source><year>2017</year><volume>16</volume><fpage>1227</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1007/s11101-017-9534-0</pub-id></element-citation></ref><ref id="B162-pharmaceuticals-13-00444"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochoa-Villarreal</surname><given-names>M.</given-names></name><name><surname>Howat</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>S.M.</given-names></name><name><surname>Jang</surname><given-names>M.O.</given-names></name><name><surname>Jin</surname><given-names>Y.W.</given-names></name><name><surname>Lee</surname><given-names>E.K.</given-names></name><name><surname>Loake</surname><given-names>G.J.</given-names></name></person-group><article-title>Plant cell culture strategies for the production of natural products</article-title><source>BMB Rep.</source><year>2016</year><volume>49</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.5483/BMBRep.2016.49.3.264</pub-id><?supplied-pmid 26698871?><pub-id pub-id-type="pmid">26698871</pub-id></element-citation></ref><ref id="B163-pharmaceuticals-13-00444"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gago</surname><given-names>J.</given-names></name><name><surname>Mart&#x000ed;nez-N&#x000fa;&#x000f1;ez</surname><given-names>L.</given-names></name><name><surname>Land&#x000ed;n</surname><given-names>M.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Artificial neural networks as an alternative to the traditional statistical methodology in plant research</article-title><source>J. Plant Physiol.</source><year>2010</year><volume>167</volume><fpage>23</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jplph.2009.07.007</pub-id><pub-id pub-id-type="pmid">19716625</pub-id></element-citation></ref><ref id="B164-pharmaceuticals-13-00444"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gago</surname><given-names>J.</given-names></name><name><surname>Mart&#x000ed;nez-N&#x000fa;&#x000f1;ez</surname><given-names>L.</given-names></name><name><surname>Landin</surname><given-names>M.</given-names></name><name><surname>Flexas</surname><given-names>J.</given-names></name><name><surname>Gallego</surname><given-names>P.P.</given-names></name></person-group><article-title>Modeling the effects of light and sucrose on in vitro propagated plants: A multiscale system analysis using artificial intelligence technology</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e85989</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0085989</pub-id><pub-id pub-id-type="pmid">24465829</pub-id></element-citation></ref><ref id="B165-pharmaceuticals-13-00444"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olden</surname><given-names>J.D.</given-names></name><name><surname>Lawler</surname><given-names>J.J.</given-names></name><name><surname>Poff</surname><given-names>N.L.</given-names></name></person-group><article-title>Machine learning methods without tears: A primer for ecologists</article-title><source>Q. Rev. Biol.</source><year>2008</year><volume>83</volume><fpage>171</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1086/587826</pub-id><pub-id pub-id-type="pmid">18605534</pub-id></element-citation></ref><ref id="B166-pharmaceuticals-13-00444"><label>166.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Landin</surname><given-names>M.</given-names></name><name><surname>Rowe</surname><given-names>R.C.</given-names></name></person-group><article-title>Artificial neural networks technology to model, understand, and optimize drug formulations</article-title><source>Formulation Tools for Pharmaceutical Development</source><publisher-name>Woodhead Publishing Limited</publisher-name><publisher-loc>Cambridge, UK</publisher-loc><year>2013</year><fpage>7</fpage><lpage>37</lpage><isbn>9781907568992</isbn></element-citation></ref><ref id="B167-pharmaceuticals-13-00444"><label>167.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gallego</surname><given-names>P.P.</given-names></name><name><surname>Gago</surname><given-names>J.</given-names></name><name><surname>Land&#x000ed;n</surname><given-names>M.</given-names></name></person-group><article-title>Artificial Neural Networks Technology to Model and Predict Plant Biology Process</article-title><source>Artificial Neural Networks</source><person-group person-group-type="editor"><name><surname>Suzuki</surname><given-names>K.</given-names></name></person-group><publisher-name>IntechOpen</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2011</year></element-citation></ref><ref id="B168-pharmaceuticals-13-00444"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Shao</surname><given-names>D.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name></person-group><article-title>Strategies for enhancing resveratrol production and the expression of pathway enzymes</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2016</year><volume>100</volume><fpage>7407</fpage><lpage>7421</lpage><pub-id pub-id-type="doi">10.1007/s00253-016-7723-1</pub-id><pub-id pub-id-type="pmid">27405437</pub-id></element-citation></ref><ref id="B169-pharmaceuticals-13-00444"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Verma</surname><given-names>P.</given-names></name><name><surname>Mathur</surname><given-names>A.</given-names></name><name><surname>Mathur</surname><given-names>A.</given-names></name></person-group><article-title>Genetic engineering approach using early Vinca alkaloid biosynthesis genes led to increased tryptamine and terpenoid indole alkaloids biosynthesis in differentiating cultures of <italic>Catharanthus roseus</italic></article-title><source>Protoplasma</source><year>2018</year><volume>255</volume><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1007/s00709-017-1151-7</pub-id><pub-id pub-id-type="pmid">28808798</pub-id></element-citation></ref><ref id="B170-pharmaceuticals-13-00444"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farag</surname><given-names>M.A.</given-names></name><name><surname>Mekky</surname><given-names>H.</given-names></name><name><surname>El-Masry</surname><given-names>S.</given-names></name></person-group><article-title>Metabolomics driven analysis of Erythrina lysistemon cell suspension culture in response to methyl jasmonate elicitation Erythrina lysistemon cell culture metabolomics</article-title><source>J. Adv. Res.</source><year>2016</year><volume>7</volume><fpage>681</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2016.07.002</pub-id><?supplied-pmid 27504198?><pub-id pub-id-type="pmid">27504198</pub-id></element-citation></ref><ref id="B171-pharmaceuticals-13-00444"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.E.</given-names></name><name><surname>Cho</surname><given-names>Y.U.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Lee</surname><given-names>D.Y.</given-names></name></person-group><article-title>Distinctive metabolomic responses of <italic>Chlamydomonas reinhardtii</italic> to the chemical elicitation by methyl jasmonate and salicylic acid</article-title><source>Process Biochem.</source><year>2016</year><volume>51</volume><fpage>1147</fpage><lpage>1154</lpage><pub-id pub-id-type="doi">10.1016/j.procbio.2016.05.029</pub-id></element-citation></ref><ref id="B172-pharmaceuticals-13-00444"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abenavoli</surname><given-names>L.</given-names></name><name><surname>Milanovic</surname><given-names>M.</given-names></name><name><surname>Procopio</surname><given-names>A.C.</given-names></name><name><surname>Spampinato</surname><given-names>G.</given-names></name><name><surname>Maruca</surname><given-names>G.</given-names></name><name><surname>Perrino</surname><given-names>E.V.</given-names></name><name><surname>Mannino</surname><given-names>G.C.</given-names></name><name><surname>Fagoonee</surname><given-names>S.</given-names></name><name><surname>Luzza</surname><given-names>F.</given-names></name><name><surname>Musarella</surname><given-names>C.M.</given-names></name></person-group><article-title>Ancient wheats: Beneficial effects on insulin resistance</article-title><source>Minerva Med.</source><year>2020</year><pub-id pub-id-type="doi">10.23736/S0026-4806.20.06873-1</pub-id></element-citation></ref><ref id="B173-pharmaceuticals-13-00444"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benmeziane-Derradji</surname><given-names>F.</given-names></name><name><surname>Derradji</surname><given-names>E.-F.</given-names></name><name><surname>Djermoune-Arkoub</surname><given-names>L.</given-names></name></person-group><article-title>Antioxidant activities and beneficial health effects of some dried fruits commonly consumed in Algeria: A review</article-title><source>Euro-Mediterranean J. Environ. Integr.</source><year>2019</year><volume>4</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1007/s41207-019-0119-8</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="pharmaceuticals-13-00444-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>In vitro-cultured plants of <italic>B. daigremontianum</italic> (<bold>left</bold>); <italic>B. &#x000d7; houghtonii</italic> (<bold>center</bold>); and <italic>B. tubiflorum</italic> (<bold>right</bold>). Bars = 1 cm; arrows indicate plantlets formed asexually on leaf margins. Original figure.</p></caption><graphic xlink:href="pharmaceuticals-13-00444-g001"/></fig><fig id="pharmaceuticals-13-00444-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Basic molecular structure of bufadienolides.</p></caption><graphic xlink:href="pharmaceuticals-13-00444-g002"/></fig><fig id="pharmaceuticals-13-00444-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Workflow diagram of <italic>Bryophyllum</italic> sp. valorization via plant tissue culture (PTC).</p></caption><graphic xlink:href="pharmaceuticals-13-00444-g003"/></fig><table-wrap id="pharmaceuticals-13-00444-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00444-t001_Table 1</object-id><label>Table 1</label><caption><p>Ethnobotanical uses of Bryophyllum species.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ethnobotanical Uses</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Organ</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Locations <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>B. crenatum</italic> (Andr.) Baker</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wounds, smallpox, otitis, cough, asthma, palpitations, headache, abscesses, convulsions, general debility, diabetes, obstetrics and gynecology, vermifuge, abortion, antimicrobial treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves<break/>Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Africa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-pharmaceuticals-13-00444" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceuticals-13-00444" ref-type="bibr">33</xref>,<xref rid="B34-pharmaceuticals-13-00444" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceuticals-13-00444" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>B. daigremontianum</italic> Raym.-Hamet et Perr.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leucorrhea, dysmenorrheal, carminative, psychic agitation, anxiety, restlessness</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-pharmaceuticals-13-00444" ref-type="bibr">28</xref>,<xref rid="B36-pharmaceuticals-13-00444" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>B. fedtschenkoi</italic> Raym.-Hamet et Perr.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Analgesic, cytotoxic, antimicrobial treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves<break/>Aerial parts Woody stems</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-pharmaceuticals-13-00444" ref-type="bibr">37</xref>,<xref rid="B38-pharmaceuticals-13-00444" ref-type="bibr">38</xref>,<xref rid="B39-pharmaceuticals-13-00444" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>B. mortagei</italic> (Raym.-Hamet et Perr.) G.E. Wickens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Digestive disorders, neoplastic diseases, vermifuge, antimicrobial treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aerial parts<break/>Flowers<break/>Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexico, Colombia, Indonesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-pharmaceuticals-13-00444" ref-type="bibr">37</xref>,<xref rid="B40-pharmaceuticals-13-00444" ref-type="bibr">40</xref>,<xref rid="B41-pharmaceuticals-13-00444" ref-type="bibr">41</xref>,<xref rid="B42-pharmaceuticals-13-00444" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>B. pinnatum</italic> (Lam.) Oken</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wounds, burns, coughs, earache, headache, muscle pain, asthma, bronchitis, pneumonia, arthritis, rheumatism, ulcers, diabetes, urinary bladder stones, dysentery, diarrhea, vermifuge, antibacterial, insect bites, fevers, menstrual disorders, nausea, tumors, gynecology</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves<break/>Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria, Uganda, Madagascar, India, China, Vietnam, Bangladesh, Australia, Brazil, Peru, Trinidad and Tobago</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-pharmaceuticals-13-00444" ref-type="bibr">43</xref>,<xref rid="B44-pharmaceuticals-13-00444" ref-type="bibr">44</xref>,<xref rid="B45-pharmaceuticals-13-00444" ref-type="bibr">45</xref>,<xref rid="B46-pharmaceuticals-13-00444" ref-type="bibr">46</xref>,<xref rid="B47-pharmaceuticals-13-00444" ref-type="bibr">47</xref>,<xref rid="B48-pharmaceuticals-13-00444" ref-type="bibr">48</xref>,<xref rid="B49-pharmaceuticals-13-00444" ref-type="bibr">49</xref>,<xref rid="B50-pharmaceuticals-13-00444" ref-type="bibr">50</xref>,<xref rid="B51-pharmaceuticals-13-00444" ref-type="bibr">51</xref>,<xref rid="B52-pharmaceuticals-13-00444" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>B. serratum</italic> (Mann. and Boit.) Blanco</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain, inflammation, fever, antiviral</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stems</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taiwan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-pharmaceuticals-13-00444" ref-type="bibr">53</xref>,<xref rid="B54-pharmaceuticals-13-00444" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>B. tubiflorum</italic> Harv.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wounds, epilepsy, vermifuge, neoplastic diseases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil, Ethiopia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-pharmaceuticals-13-00444" ref-type="bibr">29</xref>,<xref rid="B30-pharmaceuticals-13-00444" ref-type="bibr">30</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Locations where the ethnobotanical uses have been reported.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00444-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00444-t002_Table 2</object-id><label>Table 2</label><caption><p>Phenolic acids reported in <italic>Bryophyllum</italic> sp.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Subfamily</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species <sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cinnamic acids</td><td align="center" valign="middle" rowspan="1" colspan="1">p-Coumaric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B82-pharmaceuticals-13-00444" ref-type="bibr">82</xref>,<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceuticals-13-00444" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Caffeic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B79-pharmaceuticals-13-00444" ref-type="bibr">79</xref>,<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>,<xref rid="B91-pharmaceuticals-13-00444" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chlorogenic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ferulic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-pharmaceuticals-13-00444" ref-type="bibr">26</xref>,<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B82-pharmaceuticals-13-00444" ref-type="bibr">82</xref>,<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>,<xref rid="B93-pharmaceuticals-13-00444" ref-type="bibr">93</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Benzoic acids</td><td align="center" valign="middle" rowspan="1" colspan="1">p-Hydroxybenzoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B91-pharmaceuticals-13-00444" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Protocatechuic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B26-pharmaceuticals-13-00444" ref-type="bibr">26</xref>,<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B82-pharmaceuticals-13-00444" ref-type="bibr">82</xref>,<xref rid="B91-pharmaceuticals-13-00444" ref-type="bibr">91</xref>,<xref rid="B93-pharmaceuticals-13-00444" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Vanillic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B58-pharmaceuticals-13-00444" ref-type="bibr">58</xref>,<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gallic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>,<xref rid="B82-pharmaceuticals-13-00444" ref-type="bibr">82</xref>,<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>,<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceuticals-13-00444" ref-type="bibr">91</xref>,<xref rid="B93-pharmaceuticals-13-00444" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Syringic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-pharmaceuticals-13-00444" ref-type="bibr">63</xref>,<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>,<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Compounds are named as their free-form to simplify the identification. <sup>2</sup> BD: <italic>B. daigremontianum</italic>; BP: <italic>B. pinnatum</italic>; BT: <italic>B. tubiflorum</italic>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00444-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00444-t003_Table 3</object-id><label>Table 3</label><caption><p>Flavonoids reported in <italic>Bryophyllum</italic> sp.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Subfamily</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species <sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavanones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Flavones</td><td align="center" valign="middle" rowspan="1" colspan="1">Luteolin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B89-pharmaceuticals-13-00444" ref-type="bibr">89</xref>,<xref rid="B94-pharmaceuticals-13-00444" ref-type="bibr">94</xref>,<xref rid="B111-pharmaceuticals-13-00444" ref-type="bibr">111</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Apigenin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-pharmaceuticals-13-00444" ref-type="bibr">50</xref>,<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4&#x02019;,5-dihydroxy-3&#x02019;,8-dimethoxyflavone</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B109-pharmaceuticals-13-00444" ref-type="bibr">109</xref>,<xref rid="B112-pharmaceuticals-13-00444" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Acacetin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diosmetin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Afzelin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B102-pharmaceuticals-13-00444" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Galangustin</td><td align="center" valign="middle" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B58-pharmaceuticals-13-00444" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hispidulin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Flavonols</td><td align="center" valign="middle" rowspan="1" colspan="1">Quercetin</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B58-pharmaceuticals-13-00444" ref-type="bibr">58</xref>,<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>,<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>,<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceuticals-13-00444" ref-type="bibr">89</xref>,<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>,<xref rid="B94-pharmaceuticals-13-00444" ref-type="bibr">94</xref>,<xref rid="B95-pharmaceuticals-13-00444" ref-type="bibr">95</xref>,<xref rid="B109-pharmaceuticals-13-00444" ref-type="bibr">109</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Kaempferol</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>,<xref rid="B78-pharmaceuticals-13-00444" ref-type="bibr">78</xref>,<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceuticals-13-00444" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>,<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>,<xref rid="B102-pharmaceuticals-13-00444" ref-type="bibr">102</xref>,<xref rid="B109-pharmaceuticals-13-00444" ref-type="bibr">109</xref>,<xref rid="B112-pharmaceuticals-13-00444" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quercitrin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B109-pharmaceuticals-13-00444" ref-type="bibr">109</xref>,<xref rid="B112-pharmaceuticals-13-00444" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Myricetin</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP, BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>,<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>,<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rutin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B89-pharmaceuticals-13-00444" ref-type="bibr">89</xref>,<xref rid="B94-pharmaceuticals-13-00444" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Isorhamnetin</td><td align="center" valign="middle" rowspan="1" colspan="1">BD, BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>,<xref rid="B88-pharmaceuticals-13-00444" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Kaempferitrin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B102-pharmaceuticals-13-00444" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Herbacetin</td><td align="center" valign="middle" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B58-pharmaceuticals-13-00444" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Patuletin</td><td align="center" valign="middle" rowspan="1" colspan="1">BD</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Isoquercetin</td><td align="center" valign="middle" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Aromadendrin</td><td align="center" valign="middle" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Galangin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Flavanols</td><td align="center" valign="middle" rowspan="1" colspan="1">Catechin</td><td align="center" valign="middle" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B89-pharmaceuticals-13-00444" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Epicatechin</td><td align="center" valign="middle" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B92-pharmaceuticals-13-00444" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epigallocatechin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-pharmaceuticals-13-00444" ref-type="bibr">111</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Flavonoids are named as their free-form to simplify the identification. <sup>2</sup> BD: <italic>B. daigremontianum</italic>; BP: <italic>B. pinnatum</italic>; BT: <italic>B. tubiflorum</italic>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00444-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00444-t004_Table 4</object-id><label>Table 4</label><caption><p>Bufadienolides identified in <italic>Bryophyllum</italic> sp. and their associated bioactivities.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Organ</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bufadienolides</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactivities <sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11&#x003b1;,19-dihydroksytelocinobufagin, bersaldegenin-1-acetate, bersaldegenin-1,3,5-orthoacetate, 19-(acetyloxy)-3&#x003b2;,5&#x003b2;,11&#x003b1;,14-tetrahydroxyl-12-oxo-bufa-20,22-dienolide and 19-(acetyloxy)-1b,3b,5b,14-tetrahydroxyl-bufa-20,22-dienolide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate antioxidant activity using in vitro blood plasma model under peroxynitrite-induced oxidative stress. Effective for prevention of lipid hydroperoxides generation and thiobarbituric acid-reactive substances (TBARS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-pharmaceuticals-13-00444" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bryophyllin A and C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticidal against silkworm larvae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-pharmaceuticals-13-00444" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bryophyllin A and C, bersaldegenin-1-acetate, bersaldegenin-3-acetate, bersaldegenin-1,3,5-orthoacetate, daigremontianin, methyl daigremoniate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticidal against silkworm larvae, except for bersaldegenin-1-acetate.<break/>Cytotoxic effect of bersaldegenin-1,3,5-orthoacetate and daigremontianin against induced Raji cell line (Burkitt&#x02019;s lymphoma); inhibition of Epstein&#x02013;Barr virus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-pharmaceuticals-13-00444" ref-type="bibr">31</xref>,<xref rid="B67-pharmaceuticals-13-00444" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kalanhybrins A, B and C, bersaldegenin-1-acetate, bersaldegenin-3-acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity of bersaldegenin derivatives against human breast MCF-7 cancer cell line, human lung carcinoma NCI-H460 and glioblastoma SF-268 cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-pharmaceuticals-13-00444" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kalandaigremosides A-H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B124-pharmaceuticals-13-00444" ref-type="bibr">124</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bryophyllin A and B, bersaldegenin-3-acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect against keratin-forming tumor KB cell line, adenocarcinomic human alveolar basal epithelial A-549 cell line and human ileocecal carcinoma HCT-8 cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B125-pharmaceuticals-13-00444" ref-type="bibr">125</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BP, BD, BT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves (BD, BP) and stems (BT)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BP, BT: bersaldegenin-1-acetate, bersaldegenin-3-acetate, bersaldegenin-1,3,5-orthoacetate, bryophyllin A.<break/>BD: Bersaldegenin-1,3,5-orthoacetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-pharmaceuticals-13-00444" ref-type="bibr">114</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bersaldegenin-1,3,5-orthoacetate, daigremontianin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticidal against silkworm larvae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-pharmaceuticals-13-00444" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bersaldegenin-1-acetate, bersaldegenin-3-acetate, bersaldegenin-1,3,5-orthoacetate, bryophyllin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-pharmaceuticals-13-00444" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BD, BP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BD: Bersaldegenin-1-acetate, bersaldegenin-2-acetate, bersaldegenin-1,3,5-orthoacetate, bryophyllin A, daigremontianin.<break/>BP: Bersaldegenin-1-acetate, bersaldegenin-2-acetate, bersaldegenin-3-acetate, bersaldegenin-4-acetate, bersaldegenin-5-acetate, bersaldegenin-1,3,5-orthoacetate, bryophyllin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity against human ovarian cancer SKOV-3 cell line, cervical adenocarcinoma HeLa S3 cell line and malignant melanoma A375 cell line.<break/>Antimicrobial activity against <italic>Corynebacterium diphtheriae</italic>, <italic>Staphylococcus aureus</italic>, <italic>Staphylococcus epidermidis,</italic> and <italic>Enterococcus hirae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-pharmaceuticals-13-00444" ref-type="bibr">77</xref>,<xref rid="B126-pharmaceuticals-13-00444" ref-type="bibr">126</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kalantubosides A and B, bryophyllin A, bersaldegenin-1-acetate, bersaldegenin-1,3,5-orthoacetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect against adenocarcinomic human alveolar basal epithelial A-549 cell line, promyelocytic leukemia HL-60 cell line, oral adenosquamous carcinoma Cal-27 cell line, and melanoma A2058 cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-pharmaceuticals-13-00444" ref-type="bibr">127</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> BD: <italic>B. daigremontianum</italic>; BH: <italic>B. &#x000d7; houghtonii</italic>; BP: <italic>B. pinnatum</italic>; and BT: <italic>B. tubiflorum</italic>. <sup>2</sup> nd: not determined.</p></fn></table-wrap-foot></table-wrap></floats-group></article>